Document:

Exhibit 10.6

                             SUPPLEMENTAL EXECUTIVE
                              RETIREMENT AGREEMENT

                  AGREEMENT made as of the 10th day of May, 2000, between Hexcel
Corporation,  a Delaware  corporation (the "Company"),  and Ira J. Krakower (the
"Executive").

                  WHEREAS, the Executive is presently employed by the Company as
Senior Vice President, General Counsel & Secretary; and

                  WHEREAS,  the Company is willing to provide the Executive with
certain  benefits  in the event of the  retirement  from or  termination  of the
Executive's employment with the Company;

                  NOW, THEREFORE,  in consideration of the continued  employment
of the  Executive by the Company and the benefits to be derived by the Executive
hereunder, the parties mutually agree as follows:

                                    ARTICLE I
                                   DEFINITIONS

                  The following terms when used in this Agreement shall have the
designated  meaning,  unless a  different  meaning  is clearly  required  by the
context.

1.1  ACTUARIAL  EQUIVALENCE.   Determinations   hereunder  of  actuarial  value,
actuarial  equivalence  or the like shall be made by the  Company's  independent
actuary,   using  the  mortality  and  other  applicable  actuarial  assumptions
specified,  from  time to time,  in the  Hexcel  Corporation  Pension  Plan (the
"Pension Plan") or any successor plan thereto;  PROVIDED,  however, that for the
purpose of determining any lump sum amount under this  Agreement,  or the amount
of  reduction  to reflect the payment of a special  benefit  under  Section 2.3,
actuarial  equivalence  shall be determined using an interest rate equal to 120%
of the rate published by the Pension Benefit  Guaranty  Corporation for purposes
of plans  terminating  in the month in which  benefit  payments  are to commence
hereunder.

1.2 AFFILIATE. Any trade or business, whether or not incorporated,  which at the
time of reference (i) controls, is controlled by or is under common control with
the Company within the meaning of section 414(b) or (c) of the Code, or (ii) is,
together with the Company,  a member of an  affiliated  service group within the
meaning of section 414(m) of the Code.

1.3      BOARD.  The Board of Directors of the Company.

1.4      CAUSE.  Cause shall mean:

                  I.0.1 The willful and  continued  failure by the  Executive to
substantially  perform his duties with the Company  (other than any such failure
resulting from the Executive's incapability due to physical or mental illness or
any such  actual  or  anticipated  failure  after  the  issuance  of a Notice of
Termination  by the  Executive  for Good Reason)  after  demand for  substantial
performance  is delivered by the Company  specifically  identifies the manner in
which the Company  believes the  Executive has not  substantially  performed his
duties; or

                  I.0.2 The willful engaging by the Executive in misconduct that
is demonstrably and materially injurious to the Company, monetarily or otherwise
including,  but not limited to,  conduct  that would  constitute  a violation of
Section 6 of the  Executive  Severance  Agreement  if engaged in during the time
period  described  therein.  No act, or failure to act, on the Executive's  part
shall be considered  "willful" unless done, or omitted to be done, by him not in
good faith and without  reasonable belief that his action or omission was in the
best interest of the Company. Notwithstanding the foregoing, the Executive shall
not be deemed to have been  terminated for Cause without (i)  reasonable  notice
from the Board to the  Executive  setting  forth the reasons  for the  Company's
intention to terminate for Cause, (ii) delivery to the Executive of a resolution
duly adopted by the affirmative  vote of two-thirds or more of the Board then in
office  (excluding  the  Executive  if he is then a member  of the  Board)  at a
meeting of the Board called and held for such purpose,  finding that in the good
faith opinion of the Board,  the Executive was guilty of the conduct  herein set
forth and specifying the particulars thereof in detail, (iii) an opportunity for
the Executive,  together with his counsel, to be head before the Board, and (iv)
delivery to the Executive of a Notice of Termination  from the Board  specifying
the particulars thereof in detail.

1.5      CHANGE IN CONTROL.  Change in Control shall mean the first to occur of
the following events:

<PAGE>

                  I.0.1 (i) Any  person (as  defined  in Section  3(a)(9) of the
Securities  Exchange Act of 1934, as amended (the "Exchange  Act"),  as modified
and used in Section 13(d) and 14(d) of the Exchange Act, but excluding  Ciba for
so long as  Ciba  is  subject  to the  restrictions  imposed  by the  Governance
Agreement) (a "Person") is or becomes the  Beneficial  Owner (within the meaning
of Rule 13d-3  promulgated  under the Exchange Act) of 20% or more of either (A)
the then  outstanding  Common  Stock of the  Company  (the  "Outstanding  Common
Stock") or (B) the  combined  voting  power of the then  outstanding  securities
entitled to vote  generally  in the  election of  directors  of the Company (the
"Total Voting Power"); excluding, however, the following: (x) any acquisition by
the Company or any of its  affiliates  or (y) any  acquisition  by any  employee
benefit plan (or related trust) sponsored or maintained by the Company or any of
its  affiliates  and (ii) Ciba  Beneficially  Owns, in the  aggregate,  a lesser
percentage of the Total Voting Power than such Person Beneficially Owns.

                  I.0.2 A change in the  composition  of the Board such that the
individuals  who, as of the effective  date of this  Agreement,  constitute  the
Board (such  individuals  shall be  hereinafter  referred  to as the  "Incumbent
Directors") cease for any reason to constitute at least a majority of the Board;
PROVIDED,  HOWEVER,  for purposes of this  definition,  that any  individual who
becomes a  director  subsequent  to such  effective  date,  whose  election,  or
nomination  for  election by the  Company's  stockholders,  was made or approved
pursuant to the Governance  Agreement or by a vote of at least a majority of the
Incumbent  Directors (or directors whose election or nomination for election was
previously so approved)  shall be  considered a member of the  Incumbent  Board;
but,  PROVIDED,  FURTHER,  that any such individual whose initial  assumption of
office occurs as a result of either an actual or threatened election contest (as
such  terms are used in Rule  14a-11 of  Regulation  14A  promulgated  under the
Exchange Act) or other actual or threatened  solicitation of proxies or consents
by or on behalf of a person or legal entity other than the Board shall not be so
considered a member of the Incumbent Board.

<PAGE>

                  I.0.3  The  effective  date  of a  reorganization,  merger  or
consolidation  or the approval by the  stockholders  of the Company of a sale or
other  disposition  of all or  substantially  all of the  assets of the  Company
("Corporate Transaction");  excluding, however, such a Corporate Transaction (1)
pursuant to which all or  substantially  all of the individuals and entities who
are the beneficial  owners,  respectively,  of the Outstanding  Common Stock and
Total  Voting  Power  immediately  prior  to  such  Corporate  Transaction  will
beneficially own, directly or indirectly,  more than 50%,  respectively,  of the
outstanding  common stock and the combined voting power of the then  outstanding
securities  entitled  to vote  generally  in the  election of  directors  of the
company   resulting  from  such  Corporate   Transaction   (including,   without
limitation, a corporation which as a result of such transaction owns the Company
or all or  substantially  all of the Company's assets either directly or through
one or more  subsidiaries)  in  substantially  the  same  proportions  as  their
ownership,  immediately  prior to such Corporate  Transaction of the Outstanding
Common Stock and Total Voting  Power,  as the case may be, or (2) after which no
Person  beneficially  owns a greater  percentage of the combined voting power of
the then  outstanding  securities  entitled to vote generally in the election of
directors of such corporation than does Ciba.

                  I.0.4 Ciba  shall  become  the  Beneficial  Owner of more than
57.5% of the Total Voting Power.

                  I.0.5 The  approval  by the  stockholders  of the Company of a
complete liquidation or dissolution of the Company.

1.6      CIBA.  Ciba Specialty Chemicals Holding, Inc., a Swiss corporation,
together with its affiliates holding Company voting securities pursuant to
Section 4.01(b) of the Governance Agreement.

1.7      CODE.  The Internal Revenue Code of 1986, as amended.

1.8      COMPANY.  Hexcel Corporation, a Delaware corporation, and its
successors.

1.9 CONTINUOUS  SERVICE.  The number of full and partial  calendar months of the
Executive's period of continuous employment with the Company and its Affiliates.
A transfer  between  employment  with the  Company and an  Affiliate  or between
Affiliates  shall  not be  deemed  a  termination  of  employment  or  otherwise
interrupt the Executive's Continuous Service. Leaves of absence of not more than
one year and any  period  during  which the  Executive  is  entitled  to receive
disability   benefits  from  the  Company   (including  medical  and  short-term
disability benefits preceding the commencement of long-term  disability benefits
under the Company's  long-term  disability  plan) shall be taken into account as
Continuous Service.

<PAGE>

1.10  DISABILITY.  The Executive's  inability to perform the customary duties of
his  employment by reason of any medical or  psychological  illness or condition
that is expected to be permanent or of indefinite  duration,  excluding any such
illness or  condition  that  results  from  intentional  self-inflicted  injury,
alcoholism or drug abuse.

1.11     EXECUTIVE DEFERRED COMPENSATION AGREEMENT.  The Executive Deferred
Compensation Agreement between the Executive and the Company entered into as of
September 3, 1996.

1.12     EXECUTIVE SEVERANCE AGREEMENT.  The Executive Severance Agreement
entered into between the Company and the Executive as of February 3, 1999.

1.13     GOOD REASON.  Good Reason shall have the meaning set forth in the
Executive Severance Agreement.

1.14     GOVERNANCE AGREEMENT.  The agreement defined as such in the Strategic
Alliance Agreement among the Company, Ciba Geigy Limited and Ciba Geigy
Corporation, dated as of September 29, 1995, as amended.

1.15     NORMAL RETIREMENT BENEFIT. The benefit defined in Section 2.2.1 hereof.

1.16     NORMAL RETIREMENT DATE.  The date on which the Executive attains age
sixty-five (65).

1.17 NOTICE OF TERMINATION. Any termination of the Executive's employment by the
Company or by the Executive other than by death shall be communicated by written
Notice of Termination to the other party hereto. For purposes of this Agreement,
a "Notice of  Termination"  shall mean a notice  which  shall  indicate  whether
termination  was for Good Reason,  Cause,  Disability or otherwise and shall set
forth in  reasonable  detail  the facts and  circumstances  claimed to provide a
basis for  termination  of the  Executive's  employment  under the  provision so
indicated.

1.18  TERMINATION  OF  EMPLOYMENT.   References  hereunder  to  the  Executive's
termination of employment,  the date the Executive's  employment  terminates and
the like, shall, except as specifically provided herein, refer to the ceasing of
the Executive's employment with the Company and all Affiliates for any reason.

<PAGE>

                                   ARTICLE II
                               RETIREMENT BENEFITS

1.19 IN GENERAL.  The amount of the  Executive's  benefit  shall be based on his
Final  Average  Pay,  Benefit  Percentage  and Vesting  Percentage;  the benefit
otherwise  payable under this Agreement's basic benefit formula shall be reduced
by the amount of the  Executive's  Qualified  Pension  Benefits.  The  following
definitions shall apply in making benefit calculations under this Agreement:

                  II.0.1 FINAL AVERAGE PAY. The average monthly  compensation of
the Executive for the highest-paid 36 months of the Executive's  final 60 months
of Continuous Service. For this purpose (i) the Executive's "compensation" shall
mean his base salary (without regard to any salary deferral pursuant to sections
125 or 401(k) of the Code or any  successor  provision)  and all amounts  earned
(whether paid or payable) under all management incentive or other bonus plans in
which he participates  and (ii) any incentive pay or other bonus shall be deemed
to have been earned ratably over the period with respect to which it is earned.

                  II.0.2 BENEFIT  PERCENTAGE.  With respect to each of the first
60 months of  Continuous  Service,  five twelfths of one percent  (5/12%);  with
respect to each of the next 60 months of Continuous Service,  one quarter of one
percent (1/4%),  and with respect to each month of Continuous  Service after the
first 120 months of Continuous Service, one sixth of one percent (1/6%).

                  II.0.3   VESTING PERCENTAGE.  100% if the Executive has
completed at least 60 months of Continuous Service; otherwise, 0%.

<PAGE>

                  II.0.4 QUALIFIED PENSION BENEFITS.  (i) the vested benefits
paid in respect of the Executive from the Hexcel Corporation  Pension Plan or
any successor plan thereto, (ii) the  vested  contributions  made by the Company
to the  Hexcel Corporation  401(k) Plan or any successor  plan  thereto  (to
the extent paid), (iii) the vested  contributions  made by the  Company to the
Hexcel  Corporation 401(k) Restoration Plan or any successor plan thereto (to
the extent paid), and (iv) the  Executive's  Social  Security  payments,  in
each  case,  whether as a periodic payment, as a lump sum, or otherwise.  The
aggregate of the Executive's Qualified Pension Benefits shall be expressed as a
monthly amount in the form of an actuarially  equivalent  50% joint and survivor
annuity with 120 months of guaranteed payments starting at the date the
Executive attains age 65; PROVIDED, HOWEVER,  that  notwithstanding  anything
in Section 1.1 to the  contrary,  for purposes of determining  the amount of
offset  attributable  to clauses (ii) and (iii) above, Company contributions
(or allocations,  in the case of clause (iii) above)  shall be deemed to earn
interest  at an annual  rate of 6%,  compounded annually,  from the date of such
contribution (or allocation) until the date it is actually paid to or in respect
of the Executive.

1.20     PAYMENT OF BENEFITS.  Benefits shall be paid as follows:

                  II.0.1 NORMAL RETIREMENT. Subject to Section 2.2.7, and except
as otherwise set forth in Section 2.2.2 or 2.2.3, if the Executive's  employment
terminates  on or after his Normal  Retirement  Date,  the Company  will pay the
Executive  a  monthly  benefit  starting  on the  first of the  month  after his
employment  terminates  and ending  with the  payment for the month in which his
death  occurs or, if later,  after the  payment of 120 such  payments.  Any such
payments  made  after  the  death  of the  Executive  shall  be made  (i) to the
Executive's  designated  beneficiary,  if any or (ii) if there is no  designated
beneficiary  or the designated  beneficiary  dies before a total of 120 payments
have  been  made  to  the  Executive  and  the  designated  beneficiary,  to the
Executive's estate. Such monthly benefit (the "Normal Retirement Benefit") shall
be an  amount  equal  to (A) the  product  of his  Final  Average  Pay,  Benefit
Percentage, and his Vesting Percentage, less (B) his Qualified Pension Benefits.

                  II.0.2  TERMINATION  FOLLOWING  CHANGE IN CONTROL.  Subject to
Section 2.2.7,  upon (i) termination by the Executive of his employment for Good
Reason within two years following a Change in Control,  (ii)  termination of the
Executive's  employment  by the  Company  other than for Cause  within two years
following  a  Change  in  Control  or  (iii) a  termination  of the  Executive's
employment  described  in  Section  4(e) of the  Executive  Severance  Agreement
(whether by the Company or the  Executive),  the Company will pay the Executive,
no later than the next business day following the date of such  termination,  by
wire transfer to the Executive's  bank account,  as designated by the Executive,
an amount equal to the actuarial present value of the Normal Retirement  Benefit
(computed using a Vesting Percentage of 100% and Continuous Service equal to the
Executive's actual Continuous Service at the time his employment terminates plus
36 months) he would have received had he retired on his Normal  Retirement  Date
(but based upon his Final Average Pay at the time his employment terminates).

<PAGE>

                  II.0.3 TERMINATION  WITHOUT CAUSE OR FOR GOOD REASON.  Subject
to Section  2.2.7,  and except as  otherwise  provided  in Section  2.2.2,  upon
termination of the Executive's  employment at any time by the Company other than
for  Cause  or by the  Executive  for  Good  Reason,  the  Company  will pay the
Executive, as soon as practicable following such date of termination,  an amount
equal to the actuarial present value of the Normal Retirement  Benefit (computed
using  a  Vesting  Percentage  of  100%  and  Continuous  Service  equal  to the
Executive's actual Continuous Service at the time his employment terminates plus
12 months) he would have received had he retired on his Normal  Retirement  Date
(but based upon his Final Average Pay at the time his employment terminates).

                  II.0.4  TERMINATION  FOR CAUSE.  No benefits  shall be payable
hereunder  with respect to the Executive if his  employment is terminated by the
Company for Cause.

                  II.0.5  DISABILITY.  If the  Executive's  employment  with the
Company or any Affiliate terminates on account of Disability,  the Company shall
pay the  Executive  a monthly  benefit  in an amount  (computed  using a Vesting
Percentage  of 100%)  equal to (i) the  product  of his  Final  Average  Pay and
Benefit  Percentage  less (ii) his Qualified  Pension  Benefits.  The benefit so
determined  shall be payable,  without  actuarial or other  reduction to reflect
commencement  of payment  before his Normal  Retirement  Date,  beginning on the
first date of the month next  following the last month with respect to which the
Executive is entitled to payments under the Company's long term  disability plan
(or,  if earlier,  such time as the  Executive  shall elect not to receive  such
payments)  and ending with the  payment for the month in which his death  occurs
or, if later,  after the payment of 120 such  payments.  Any such  payments made
after the death of the Executive shall be made (i) to the Executive's designated
beneficiary,  if any or  (ii)  if  there  is no  designated  beneficiary  or the
designated beneficiary dies before a total of 120 payments have been made to the
Executive and the designated beneficiary, to the Executive's estate.

<PAGE>

                  II.0.6 OTHER TERMINATION. Subject to Section 2.2.7, and except
as  otherwise  set forth in Sections  2.2.2,  2.2.3 or 2.2.5,  if the  Executive
terminates  his  employment  prior to his attainment of age 65, the Company will
pay the  Executive  a  monthly  benefit  starting  on the  date  elected  by the
Executive,  but no earlier than the first of the month after his  attainment  of
age 55, and ending with the payment for the month in which his death  occurs or,
if later,  after the payment of 120 such payments.  Any such payments made after
the  death of the  Executive  shall be made  (i) to the  Executive's  designated
beneficiary,  if any or  (ii)  if  there  is no  designated  beneficiary  or the
designated beneficiary dies before a total of 120 payments have been made to the
Executive  and the  designated  beneficiary,  to the  Executive's  estate.  Such
monthly  benefit shall be calculated  and paid in accordance  with Section 2.2.1
hereof,  reduced by one quarter of one percent  (1/4%) per payment for each full
calendar month by which the benefit  commencement  date precedes the Executive's
attainment of age 65.

                  II.0.7  OPTIONAL  FORMS  OF  BENEFIT.  In lieu of the  form of
benefit  prescribed in Section 2.2.1 and Section 2.2.6,  the Executive may elect
to receive his benefit hereunder,  as soon as practicable  following the date of
his  termination  of  employment,  in a cash lump sum, the amount of which shall
equal the actuarial  present value of, in the case of Section 2.2.1,  his Normal
Retirement  Benefit  and,  in the case of Section  2.2.6,  the  reduced  monthly
benefit  he  would  have  received  thereunder.  In lieu of the lump sum form of
benefit  prescribed  in Sections  2.2.2.  and 2.2.3,  the Executive may elect to
receive his benefit  hereunder as a monthly benefit starting on the first of the
month after his employment  terminates and ending with the payment for the month
in which his death occurs or, if later,  after the payment of 120 such payments.
Any such payments made after the death of the Executive shall be made (i) to the
Executive's  designated  beneficiary,  if any or (ii) of there is no  designated
beneficiary  or the designated  beneficiary  dies before a total of 120 payments
have  been  made  to  the  Executive  and  the  designated  beneficiary,  to the
Executive's  estate.  Any  election  to  change  to or from the lump sum form of
benefit  that is  made  by the  Executive  less  than  one  year  preceding  the
Executive's date of termination  shall not be given effect;  PROVIDED,  HOWEVER,
that the foregoing shall be  inapplicable  with respect to (i) any election made
by the  Executive  within  30 days of the  date of this  Agreement  and (ii) any
election  with respect to the  Executive's  benefit  under  Section 2.2.2 to the
extent such election is made at least 90 days prior to a Change in Control or at
any time prior to the Company  entering  into an agreement the  consummation  or
shareholder approval of which would constitute a Change in Control.

<PAGE>

1.21  SPECIAL  BENEFIT.  If it shall  be  determined  by a final  administrative
decision of the Internal  Revenue (which is not appealed by the Executive) or by
a final decision of a court of competent  jurisdiction (which is not appealed by
the Executive) that the value of all or any part of any benefit  contemplated by
this Agreement is includable in the income of the Executive  prior to the actual
receipt  of such  benefit,  the  Company  shall  make a special  payment  to the
Executive,  in discharge  of the  actuarially  equivalent  value (based upon the
actuarial  factors in effect when benefits  other than the benefit  described in
this Section 2.3 commence to be paid to the Executive hereunder) of any benefits
otherwise due hereunder  (and such other benefit shall be reduced to reflect the
actuarial  value of any such special payment made pursuant to this Section 2.3),
in an amount equal to the Executive's estimated federal,  state and local income
tax liabilities related to such inclusion and to the inclusion in income of such
special  payment.   The  Executive  shall  have  no  obligation  to  appeal  any
determination  made by the Internal  Revenue Service or the decision of any such
court.

1.22     NO DUPLICATION.  Except as provided in Section 2.3 hereof, in no event
shall benefits become payable to the Executive under more than one Section of
this Article II.

                                   ARTICLE III
                                SURVIVOR BENEFITS

1.23 POST-RETIREMENT  SURVIVOR BENEFIT.  Notwithstanding any provision hereof to
the contrary,  the Executive may elect, at any time prior to commencement of his
benefits  under  Article II (and may revoke or modify any such  election  and/or
make a new  election,  in each case at any time and from  time to time  prior to
commencement  of his benefits under Article II), to have his benefit paid in the
from of a joint  and  survivor  annuity  pursuant  to which (i)  payment  of the
Executive's  benefit will be made in accordance  with Article II and (ii) if the
Executive dies after payment of his benefits  under Article II has started,  the
Company shall pay a monthly benefit to the Executive's  designated  beneficiary,
starting on the first of the month immediately  following the month in which the
Executive dies or, if later, with the month immediately following the last month
for which a payment is made to such  beneficiary  under  Article  II, and ending
with the payment for the month in which the death of such designated beneficiary
occurs. Such monthly benefit shall be an amount equal to 50% or 100%, as elected
by the Executive,  of the monthly  benefit the Executive was receiving under the
Agreement prior to his death. If the Executive makes such election,  the benefit
payable to the Executive under Article II hereof shall be reduced to reflect the
actuarial  equivalence of the  additional  Post-Retirement  Survivor  Benefit so
elected by the Executive.

<PAGE>

1.24  PRE-RETIREMENT  SURVIVOR BENEFIT.  Notwithstanding any provision hereof to
the contrary,  the Executive may elect at any time (and may revoke or modify any
such election and/or make a new election, in each case at any time and from time
to time prior to  commencement  of his benefits  under  Article II) that, in the
event the Executive  dies before  distribution  of his benefits under Article II
has  started,  the  Company  shall  pay a  monthly  benefit  to the  Executive's
designated beneficiary, starting on the first of the month immediately following
the month in which the Executive  dies, but in no event earlier than the date on
which the Executive would have been eligible to commence receipt of his benefits
under Article II had he terminated  employment on the day immediately  preceding
his death,  and ending with the payment for the month in which the death of such
designated  beneficiary occurs. Such monthly benefit shall be an amount equal to
50% or 100%, as elected by the Executive,  of the monthly  benefit the Executive
would  have  received  had  he  terminated  employment  on the  day  immediately
preceding  his death and  commenced  benefits  on the date on which the  benefit
under this Section 3.2  commences.  If the Executive  makes such  election,  the
benefit  payable to the  Executive  under  Article II hereof shall be reduced to
reflect the actuarial  equivalence  of the  additional  Pre-Retirement  Survivor
Benefit so elected by the Executive.

                                   ARTICLE IV
                                  MISCELLANEOUS

1.25     BINDING AGREEMENT.  This Agreement and all rights of the Executive
hereunder shall inure to the benefit of and be enforceable by the Executive's
person or legal representatives, executors, administrators, successors, heirs,
distributees, devisees and legatees.

1.26 NOTICE. Notices,  elections,  demands and all other communications provided
for in this Agreement  shall be in writing and shall be deemed to have been duly
given when delivered by hand (or received by telecopy,  telex or similar device)
or mailed  by  United  States  certified  or  registered  mail,  return  receipt
requested, postage prepaid, addressed as follows:

                  If to the Executive:

                           Mr. Ira J. Krakower
                           21 Walworth Avenue
                           Scarsdale, New York  10583

<PAGE>
                  If to the Company:

                           Hexcel Corporation
                           Two Stamford Plaza
                           281 Tresser Boulevard
                           Stamford, Connecticut  06901-3238

                           Attn:  Vice President - Human Resources

or to such other address as any party may have furnished to the other in writing
in  accordance  herewith,  except  that  notices of change of  address  shall be
effective only upon receipt.

1.27 GENERAL PROVISIONS.  No provision of this Agreement may be modified, waived
or  discharged  unless such  waiver,  modification  or discharge is agreed to in
writing  signed by the  Executive  and such  officer  of the  Company  as may be
specifically  designated  by the Board.  No waiver by either party hereto at any
time of any  breach by the  other  party  hereto  of, or  compliance  with,  any
condition  or  provision  of this  Agreement to be performed by such other party
shall be deemed a waiver of similar or  dissimilar  provisions  or conditions at
the same or at any prior or subsequent  time. No agreements or  representations,
oral or otherwise, express or implied, with respect to the subject matter hereof
have been  made by  either  party  which  are not set  forth  expressly  in this
Agreement.  The validity,  interpretation,  construction and performance of this
Agreement  shall be governed by the laws of the State of New York without regard
to its conflicts of law principles.

1.28 VALIDITY. The invalidity or unenforceability of any provision or provisions
of this Agreement shall not affect the validity or  enforceability  of any other
provision of this Agreement, which shall remain in full force and effect.

1.29  COUNTERPARTS.  This Agreement may be executed in one or more counterparts,
each of which shall be deemed to be an original but all of which  together  will
constitute one and the same instrument.

1.30 ARBITRATION. Except as set forth in Section 4.9, any dispute or controversy
arising under or in connection with this Agreement shall be settled  exclusively
by arbitration,  conducted  before a panel of three  arbitrators in the State of
New York, in accordance with the rules of the American  Arbitration  Association
then in effect.  Judgment may be entered on the arbitrator's  award in any court
having jurisdiction.

<PAGE>

1.31 ENTIRE  AGREEMENT.  This Agreement  sets forth the entire  agreement of the
parties hereto in respect of the subject matter  contained herein and supersedes
all  prior  agreements,  promises,  covenants,   arrangements,   communications,
representations or warranties, whether oral or written, by any officer, employee
or  representative  of any party hereto;  and any prior agreement of the parties
hereto in respect of the subject matter  contained  herein is hereby  terminated
and  cancelled;  PROVIDED,  however,  that this  Agreement  shall  supersede the
Executive  Deferred  Compensation  Agreement only after the Executive's  Vesting
Percentage  hereunder  is,  or is  deemed  to be,  100%,  after  which  time the
Executive  Deferred  Compensation  Agreement  shall be of no  further  force and
effect.

1.32 NO RIGHT OF OFFSET.  The amount of any payment or benefit  provided  for in
this Agreement shall not be reduced by any compensation  earned by the Executive
as a result of employment by another employer, by retirement benefits (except as
otherwise  set forth in this  Agreement),  by offset  against any amount owed or
claimed to be owed by the Executive to the Company, or otherwise.

1.33 PROTECTIVE  PROVISIONS.  The Executive and the Company shall cooperate with
each other by furnishing any and all  information  and  computations  reasonably
requested by the other in order to determine the amounts payable hereunder or to
facilitate  the payment of benefits  hereunder.  If upon written  request of the
Company,  the  Executive  shall,  within  ninety days  thereof  (180 days if the
Executive is  Disabled),  if such  information  is  reasonably  available to the
Executive,  fail to comply with such a request for information,  the Company may
terminate any benefits otherwise payable under this Agreement.

1.34  ASSIGNMENT.  The  voluntary  or  involuntary  assignment,  encumbrance  or
alienation  of any benefit  hereunder  or any interest  therein,  whether or not
payable to the Executive, is not permitted and will not be recognized.  Any such
purported  assignment,  encumbrance  or  alienation,  by  operation  of  law  or
otherwise,  shall be void.  Subject to the  provisions  of  applicable  law,  no
payment of 1.1

<PAGE>

any benefit  shall,  prior to actual  receipt  thereof by the  Executive  or his
designated beneficiary, be subject to garnishment,  attachment,  execution, levy
or other legal process for debts or for alimony or support of any spouse, former
spouse or other relative.

                                                     HEXCEL CORPORATION

                                                     By:____________________
                                                     Name:
                                                     Title:

                                                     --------------------
                                                     Ira J. Krakower

<PAGE>

                                TABLE OF CONTENTS

ARTICLE I

DEFINITIONS....................................................................1
         1.1      Actuarial Equivalence........................................1
         1.2      Affiliate....................................................2
         1.3      Board........................................................2
         1.4      Cause........................................................2
         1.5      Change in Control............................................2
         1.6      Ciba.........................................................4
         1.7      Code.........................................................4
         1.8      Company......................................................4
         1.9      Continuous Service...........................................4
         1.10     Disability...................................................4
         1.11     Executive Deferred Compensation Agreement....................5
         1.12     Executive Severance Agreement................................5
         1.13     Good Reason..................................................5
         1.14     Governance Agreement.  ......................................5
         1.15     Normal Retirement Benefit....................................5
         1.16     Normal Retirement Date.......................................5
         1.17     Notice of Termination........................................5
         1.18     Termination of Employment....................................5

ARTICLE II

RETIREMENT BENEFITS............................................................6
         2.1      In General.  ................................................6
         2.2      Payment of Benefits..........................................7
         2.3      Special Benefit..............................................9
         2.4      No Duplication..............................................10

ARTICLE III

SURVIVOR BENEFITS.............................................................10
         3.1      Post-Retirement Survivor Benefit............................10
         3.2      Pre-Retirement Survivor Benefit.............................10

ARTICLE IV

MISCELLANEOUS.................................................................11
         4.1      Binding Agreement...........................................11
         4.2      Notice......................................................11
         4.3      General Provisions..........................................12
         4.4      Validity....................................................12
         4.5      Counterparts................................................12
         4.6      Arbitration.................................................12
         4.7      Entire Agreement............................................12
         4.8      No Right of Offset..........................................13
         4.9      Protective Provisions.......................................13
         4.10     Assignment..................................................13

<PAGE>WARRANT

                           To Purchase Common Stock of

                              CONSECO FINANCE CORP.

                                                       Warrant No. 1
                                             No. of Shares of Common Stock: 5.42

<PAGE>

                                TABLE OF CONTENTS

                                                                           Page

1.   DEFINITIONS..............................................................1

2.   EXERCISE OF WARRANT......................................................4

         2.1.   Manner of Exercise............................................4

         2.2.   Payment of Taxes..............................................5

         2.3.   Fractional Shares.............................................5

         2.4.   Continued Validity............................................5

3.   TRANSFER, DIVISION AND COMBINATION.......................................6

         3.1.   Transfer......................................................6

         3.2.   Division and Combination......................................6

         3.3.   Expenses......................................................6

         3.4.   Maintenance of Books..........................................6

4.   ANTIDILUTION PROVISIONS..................................................7

         4.1.   Stock Dividends, Subdivisions and Combinations................7

         4.2.   Certain Other Distributions...................................7

         4.3.   Issuance of Additional Shares of Common Stock.................8

         4.4.   Issuance of Warrants or Other Rights..........................9

         4.5.   Issuance of Convertible Securities............................9

         4.6.   Superseding Adjustment........................................10

         4.7.   Other Provisions Applicable to Adjustments under this
                  Section.....................................................10

         4.8.   Reorganization, Reclassification, Merger, Consolidation or
                  Disposition of Assets; Sale of Controlling Interest.........14

         4.9.   Other Action Affecting Common Stock...........................15

         4.10.  No Adjustment Required........................................15

5.       NOTICES TO WARRANT HOLDERS...........................................15

         5.1.   Notice of Adjustments.........................................15

         5.2.   Notice of Corporate Action....................................16

         5.3.   Notice to Stockholders........................................16

6.       NO IMPAIRMENT........................................................16

                                       i
<PAGE>

7.       RESERVATION AND AUTHORIZATION OF COMMON STOCK; REGISTRATION WITH
           OR APPROVAL OF ANY GOVERNMENTAL AUTHORITY..........................17

8.       TAKING OF RECORD; STOCK AND WARRANT TRANSFER BOOKS...................18

9.       RESTRICTIONS ON TRANSFERABILITY......................................18

         9.1.   Restrictive Legend............................................18

         9.2.   Notice of Proposed Transfers; Requests for Registration.......19

         9.3.   Incidental Registration.......................................20

         9.4.   Registration Procedures.......................................20

         9.5.   Expenses......................................................21

         9.6.   Indemnification and Contribution..............................22

         9.7.   Termination of Restrictions...................................24

         9.8.   Listing on Securities Exchange................................24

         9.9.   Certain Limitations on Registration Rights....................24

10.      SUPPLYING INFORMATION................................................25

11.      LOSS OR MUTILATION...................................................25

12.      OFFICE OF THE COMPANY................................................25

13.      FINANCIAL AND BUSINESS INFORMATION...................................25

         13.1.  Quarterly Information.........................................25

         13.2.  Annual Information............................................25

         13.3.  Filings.......................................................26

         13.4.  Access........................................................26

         13.5.  EDGAR Filings.................................................26

14.      REPURCHASE BY THE COMPANY OF WARRANT AND WARRANT STOCK...............26

         14.1.  Obligation to Repurchase Warrant and Warrant Stock............26

         14.2.  Determination and Payment of Repurchase Price.................27

         14.3.  Option to Repurchase Warrant and Warrant Stock................28

15.      APPRAISAL............................................................28

16.      LIMITATION OF LIABILITY..............................................28

17.      MISCELLANEOUS........................................................29

                                      ii
<PAGE>

         17.1.  Nonwaiver and Expenses........................................29

         17.2.  Notice Generally..............................................29

         17.3.  Indemnification...............................................30

         17.4.  Remedies......................................................30

         17.5.  Successors and Assigns........................................30

         17.6.  Amendment.....................................................30

         17.7.  Severability..................................................30

         17.8.  Headings......................................................30

         17.9.  Governing Law.................................................31

         17.10. Effective Date................................................31

EXHIBITS
Exhibit A     -  Subscription Form
Exhibit B     -  Assignment Form

                                      iii

<PAGE>

THIS WARRANT AND THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE TRANSFERRED IN
VIOLATION OF SUCH ACT, THE RULES AND REGULATIONS THEREUNDER OR THE PROVISIONS OF
THIS WARRANT.

No. of Shares of Common Stock:  5.42                               Warrant No. 1

                                     WARRANT

                           To Purchase Common Stock of

                              CONSECO FINANCE CORP.

              THIS IS TO CERTIFY THAT LEHMAN BROTHERS HOLDINGS INC. "Lehman", or
registered assigns, is entitled, at any time prior to the Expiration Date (as
hereinafter defined), to purchase from Conseco Finance Corp., a Delaware
corporation (the "Company"), 5.42 shares of Common Stock (as hereinafter defined
and subject to adjustment as provided herein), in whole or in part, including
fractional parts, at a purchase price of $0.01 per share, all on the terms and
conditions and pursuant to the provisions hereinafter set forth. This warrant is
being issued in connection with the transactions contemplated in the Amended and
Restated Master Repurchase Agreement dated May 9, 2000 by and between Lehman
Commercial Paper Inc. and Green Tree Finance Corp. - Five.

1.   DEFINITIONS

              As used in this Warrant, the following terms have the respective
meanings set forth below:

              "Additional Shares of Common Stock" means any shares of Common
Stock issued by the Company after the Closing Date other than Warrant Stock.

              "Appraised Value" means, in respect of any share of Common Stock
on any date herein specified, the fair saleable value of such share of Common
Stock (determined without giving effect to the discount for (i) a minority
interest or (ii) any lack of liquidity of the Common Stock or to the fact that
the Company may have no class of equity registered under the Exchange Act) as of
the last day of the most recent fiscal month end prior to such date specified,
based on the value of the Company, as determined by an investment banking firm
selected in accordance with the terms of Section 15, divided by the number of
Fully Diluted Outstanding shares of Common Stock.

              "Business Day" means any day that is not a Saturday or Sunday or a
day on which banks are required or permitted to be closed in the State of New
York.

              "Closing Date" means May 11, 2000.

              "Commission" means the Securities and Exchange Commission or any

                                        1

<PAGE>

other federal agency then administering the Securities Act and other federal
securities laws.

              "Common Stock" means (except where the context otherwise
indicates) the Common Stock, $.01 par value, of the Company as constituted on
the Closing Date, and any capital stock into which such Common Stock may
thereafter be changed, and shall also include (i) capital stock of the Company
of any other class (regardless of how denominated) issued to the holders of
shares of Common Stock upon any reclassification thereof which is also not
preferred as to dividends or assets on liquidation over any other class of stock
of the Company and which is not subject to redemption and (ii) shares of common
stock of any successor or acquiring corporation (as defined in Section 4.8)
received by or distributed to the holders of Common Stock of the Company in the
circumstances contemplated by Section 4.8.

              "Convertible Securities" means evidences of indebtedness, shares
of stock or other securities which are convertible into or exchangeable, with or
without payment of additional consideration in cash or property, for Additional
Shares of Common Stock, either immediately or upon the occurrence of a specified
date or a specified event.

              "Current Market Price" means, in respect of any share of Common
Stock on any date herein specified, if there shall not then be a public market
for the Common Stock, the Appraised Value per share of Common Stock as at such
date, or if there shall then be a public market for the Common Stock, the
average of the daily market prices for 30 consecutive Business Days commencing
45 days before such date. The daily market price for each such Business Day
shall be (i) the last sale price on such day on the principal stock exchange on
which such Common Stock is then listed or admitted to trading, (ii) if no sale
takes place on such day on any such exchange, the average of the last reported
closing bid and asked prices on such day as officially quoted on any such
exchange, (iii) if the Common Stock is not then listed or admitted to trading on
any stock exchange, the average of the last reported closing bid and asked
prices on such day in the over-the-counter market, as furnished by the National
Association of Securities Dealers Automatic Quotation System or the National
Quotation Bureau, Inc., (iv) if neither such corporation at the time is engaged
in the business of reporting such prices, as furnished by any similar firm then
engaged in such business, or (v) if there is no such firm, as furnished by any
member of the NASD selected mutually by Holder and the Company or, if they
cannot agree upon such selection, an investment banking firm of recognized
national standing as selected by two such members of the NASD, one of which
shall be selected by Holder and one of which shall be selected by the Company.

              "Current Warrant Price" means, in respect of a share of Common
Stock at any date herein specified, the price at which a share of Common Stock
may be purchased pursuant to this Warrant on such date. As of the date hereof,
the Current Warrant Price shall be $.01 per share.

              "Exchange Act" means the Securities Exchange Act of 1934, as
amended,

                                       2

<PAGE>

or any similar federal statute, and the rules and regulations of the Commission
thereunder, all as the same shall be in effect from time to time.

              "Exercise Period" means the period during which this Warrant is
exercisable pursuant to Section 2.1.

              "Expiration Date" means the earlier of (i) May 11, 2005 and (ii)
the occurrence of an event described in Section 4.8(b).

              "Fully Diluted Outstanding" means, when used with reference to
Common Stock, at any date as of which the number of shares thereof is to be
determined, all shares of Common Stock Outstanding at such date and all shares
of Common Stock issuable in respect of the Warrants and other options or
warrants to purchase, or securities convertible into, shares of Common Stock
outstanding on such date whether or not then exercisable or convertible.

              "GAAP" means generally accepted accounting principles in the
United States of America as from time to time in effect.

              "Holder" means the Person in whose name the Warrant set forth
herein is registered on the books of the Company maintained for such purpose.

              "NASD" means the National Association of Securities Dealers, Inc.,
or any successor corporation thereto.

              "Other Property" has the meaning set forth in Section 4.8.

              "Outstanding" means, when used with reference to Common Stock, at
any date as of which the number of shares thereof is to be determined, all
issued shares of Common Stock, except shares then owned or held by or for the
account of the Company or any subsidiary thereof, and shall include all shares
issuable in respect of outstanding scrip or any certificates representing
fractional interests in shares of Common Stock.

              "Person" means any individual, sole proprietorship, partnership,
joint venture, trust, incorporated organization, association, corporation,
limited liability company, institution, public benefit corporation, entity or
government (whether federal, state, county, city, municipal or otherwise,
including, without limitation, any instrumentality, division, agency, body or
department thereof).

              "Repurchase Price" has the meaning specified in Section 14.2.

              "Restricted Common Stock" means shares of Common Stock which are,
or which upon their issuance on the exercise of any Warrant would be, evidenced
by a certificate bearing the restrictive legend set forth in Section 9.1(a).

              "Securities Act" means the Securities Act of 1933, as amended, or
any

                                        3
<PAGE>

similar federal statute, and the rules and regulations of the Commission
thereunder, all as the same shall be in effect at the time.

              "Transfer" means any sale, exchange, transfer, pledge,
hypothecation or other disposition, directly or indirectly (including, without
limitation, by means of a derivative security) of any Warrant or Warrant Stock
or of any interest in either thereof.

              "Transfer Notice" has the meaning specified in Section 9.2.

              "Warrant Price" means an amount equal to (i) the number of shares
of Common Stock being purchased upon exercise of this Warrant pursuant to
Section 2.1, multiplied by (ii) the Current Warrant Price, rounded (if including
a fraction of a penny) to the next highest penny.

              "Warrant Stock" means the shares of Common Stock purchased by the
holders of the Warrants upon the exercise thereof.

              "Warrants" means this Warrant and all warrants issued upon
transfer, division or combination of, or in substitution for, any thereof. All
Warrants shall at all times be identical as to terms and conditions and date,
except as to the number of shares of Common Stock for which they may be
exercised.

2.   EXERCISE OF WARRANT

        2.1.  Manner of Exercise.  From and after the Closing Date and until
5:00 P.M., New York time, on the Expiration Date, Holder may exercise this
Warrant, on any Business Day, for all or any part of the number of shares of
Common Stock purchasable hereunder.

              In order to exercise this Warrant, in whole or in part, Holder
shall deliver to the Company at its principal office at 1100 Landmark Towers,
345 Saint Peters Street, Saint Paul, Minnesota 55102-1639 or at the office or
agency designated by the Company pursuant to Section 12, (i) a written notice of
Holder's election to exercise this Warrant, which notice shall specify the
number of shares of Common Stock to be purchased, (ii) payment of the Warrant
Price and (iii) this Warrant. Such notice shall be substantially in the form of
the subscription form appearing at the end of this Warrant as Exhibit A, duly
executed by Holder or its agent or attorney. Upon receipt thereof, the Company
shall, as promptly as practicable, and in any event within five (5) Business
Days thereafter, execute or cause to be executed and deliver or cause to be
delivered to Holder a certificate or certificates representing the aggregate
number of shares of Common Stock issuable upon such exercise, together (if the
Company elects to pay cash in lieu of fractional shares) with cash in lieu of
any fraction of a share, as hereinafter provided. The stock certificate or
certificates so delivered shall be, to the extent possible, in such denomination
or denominations as Holder shall request in the notice and shall be registered
in the name of Holder or, subject to Section 9, such other name as shall

                                       4
<PAGE>

be designated in the notice. This Warrant shall be deemed to have been exercised
and such certificate or certificates shall be deemed to have been issued, and
Holder or any other Person so designated to be named therein shall be deemed to
have become a holder of record of such shares for all purposes, as of the date
the notice, together with the cash or check or checks and this Warrant, is
received by the Company as described above and all taxes required to be paid by
Holder, if any, pursuant to Section 2.2 prior to the issuance of such shares
have been paid. If this Warrant shall have been exercised in part, the Company
shall, at the time of delivery of the certificate or certificates representing
Warrant Stock, deliver to Holder a new Warrant evidencing the rights of Holder
to purchase the unpurchased shares of Common Stock called for by this Warrant,
which new Warrant shall in all other respects be identical with this Warrant,
or, at the request o Holder, appropriate notation may be made on this Warrant
and the same returned to Holder. Payment of the Warrant Price may be made by
cash or certified or official bank check.

        2.2. Payment of Taxes. All shares of Common Stock issuable upon the
exercise of this Warrant pursuant to the terms hereof shall be validly issued
and, upon payment of the Warrant Price, fully paid and nonassessable and without
any preemptive rights. The Company shall pay all expenses in connection with,
and all taxes and other governmental charges that may be imposed with respect
to, the issue or delivery thereof. The Company shall not be required, however,
to pay any tax or other charge imposed in connection with any transfer involved
in the issue of any certificate for shares of Common Stock issuable upon
exercise of this Warrant in any name other than that of Holder, and in such case
the Company shall not be required to issue or deliver any stock certificate
until such tax or other charge has been paid or it has been established to the
satisfaction of the Company that no such tax or other charge is due.

        2.3. Fractional Shares. The Company shall not be required to issue a
fractional share of Common Stock upon exercise of any Warrant. As to any
fraction of a share which Holder of one or more Warrants, the rights under which
are exercised in the same transaction, would otherwise be entitled to purchase
upon such exercise, the Company shall (if it elects not to issue a fractional
share) pay a cash adjustment in respect of such final fraction in an amount
equal to the same fraction of the Current Market Price per share of Common Stock
on the date of exercise.

        2.4.  Continued Validity. A holder of shares of Common Stock issued
upon the exercise of this Warrant, in whole or in part (other than a holder who
acquires such shares after the same have been publicly sold pursuant to a
Registration Statement under the Securities Act or sold pursuant to Rule 144
thereunder), shall continue to be entitled with respect to such shares to all
rights, and shall be subject to all obligations, to which it would have been
entitled or subject as Holder under Sections 9, 10, 13, 14 and 17 of this
Warrant. The Company will, at the time of each exercise of this Warrant, in
whole or in part, upon the request of the holder of the shares of Common Stock
issued upon such exercise hereof, acknowledge in writing, in a form reasonably
satisfactory to
                                       5

<PAGE>

such holder, its continuing obligation to afford to such holder all such rights,
and such holder, at the request of the Company, shall acknowledge in writing, in
a form reasonably acceptable to the Company, its continuing obligations to the
Company; provided, however, that if such holder or the Company shall fail to
make any such request, such failure shall not affect the continuing obligation
of the Company or such holder, as the case may be.

3.   TRANSFER, DIVISION AND COMBINATION

        3.1.  Transfer.  Subject to compliance with Sections 9 and 14, transfer
of this Warrant and all rights hereunder, in whole or in part, shall be
registered on the books of the Company to be maintained for such purpose, upon
surrender of this Warrant at the principal office of the Company referred to in
Section 2.1 or the office or agency designated by the Company pursuant to
Section 12, together with a written assignment of this Warrant substantially in
the form of Exhibit B hereto duly executed by Holder or its agent or attorney
and if such transfer is not to be made pursuant to Section 14, funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such
surrender and, if required, such payment, the Company shall, subject to Section
9, execute and deliver a new Warrant or Warrants each dated the same dates as
the surrendered Warrant in the name of the assignee or assignees and in the
denomination specified in such instrument of assignment, and shall issue to the
assignor a new Warrant evidencing the portion of this Warrant not so assigned,
and this Warrant shall promptly be cancelled. A Warrant, if properly assigned in
compliance with Section 9, may be exercised by a new Holder for the purchase of
shares of Common Stock without having a new Warrant issued.

        3.2. Division and Combination.  Subject to Section 9, this Warrant may
be divided or combined with other Warrants upon presentation hereof at the
aforesaid office or agency of the Company, together with a written notice
specifying the names and denominations in which new Warrants are to be issued,
signed by Holder or its agent or attorney. Subject to compliance with Section
3.1 and with Section 9, as to any transfer which may be involved in such
division or combination, the Company shall execute and deliver a new Warrant or
Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice.

        3.3.  Expenses.  The Company shall prepare, issue and deliver at its
own expense (other than transfer taxes) the new Warrant or Warrants under this
Section 3.

        3.4. Maintenance of Books. The Company agrees to maintain, at its
aforesaid office or agency, books for the registration and the registration of
transfer of the Warrants.

                                      6
<PAGE>

4.   ANTIDILUTION PROVISIONS

              The number of shares of Common Stock for which this Warrant is

exercisable, and the price at which such shares may be purchased upon exercise
of this Warrant, shall be subject to adjustment from time to time as set forth
in this Section 4. The Company shall give Holder notice of any event described
below which requires an adjustment pursuant to this Section 4 in accordance with
Sections 5.1 and 5.2.

        4.1.  Stock Dividends, Subdivisions and Combinations.  If at any time
the Company shall:

              (a) take a record of the holders of its Common Stock for the
        purpose of entitling them to receive a dividend payable in, or other
        distribution of, Additional Shares of Common Stock,

              (b) subdivide its outstanding shares of Common Stock into a larger
        number of shares of Common Stock, or

              (c) combine its outstanding shares of Common Stock into a smaller
        number of shares of Common Stock,

then (i) the number of shares of Common Stock for which this Warrant is
exercisable immediately after the occurrence of any such event shall be adjusted
to equal the number of shares of Common Stock which a record holder of the same
number of shares of Common Stock for which this Warrant is exercisable
immediately prior to the occurrence of such event would own or be entitled to
receive after the happening of such event, and (ii) subject to Section 4.10, the
Current Warrant Price shall be adjusted to equal (A) the Current Warrant Price
multiplied by the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to the adjustment divided by (B) the number of
shares of Common Stock for which this Warrant is exercisable immediately after
such adjustment.

        4.2.  Certain Other Distributions.  If at any time the Company shall
take a record of the holders of its Common Stock for the purpose of entitling
them to receive any dividend or other distribution (in each case other than a
dividend or other distribution permitted by Item 4 of Exhibit B to the
Agreement, dated May 11, 2000, among Conseco, Inc., the Company, Lehman and
CIHC, Incorporated) of:

              (a) cash (other than a cash dividend payable out of earnings or
        earned surplus legally available for the payment of dividends under the
        laws of the jurisdiction of incorporation of the Company),

              (b) any evidences of its indebtedness, any shares of stock of any
        class or any other securities or property of any nature whatsoever
        (other than cash, Convertible Securities or Additional Shares of Common
        Stock), or

              (c) any warrants or other rights to subscribe for or purchase any
        evidences of its indebtedness, any shares of stock of any class or any
        other

                                       7
<PAGE>

        securities or property of any nature whatsoever (other than cash,
        Convertible Securities or Additional Shares of Common Stock),

then (i) the number of shares of Common Stock for which this Warrant is
exercisable shall be adjusted to equal the product of the number of shares of
Common Stock for which this Warrant is exercisable immediately prior to such
adjustment by a fraction (A) the numerator of which shall be the Current Market
Price per share of Common Stock at the date of taking such record and (B) the
denominator of which shall be such Current Market Price per share of Common
Stock minus the amount allocable to one share of Common Stock of any such cash
so distributable and of the fair value (as determined in good faith by the Board
of Directors of the Company and supported by an opinion from an investment
banking firm of recognized national standing acceptable to Holder (which
acceptance shall not be unreasonably withheld or delayed)) of any and all such
evidences of indebtedness, shares of stock, other securities or property or
warrants or other subscription or purchase rights so distributable, and (ii)
subject to Section 4.10, the Current Warrant Price shall be adjusted to equal
(A) the Current Warrant Price multiplied by the number of shares of Common Stock
for which this Warrant is exercisable immediately prior to the adjustment
divided by (B) the number of shares of Common Stock for which this Warrant is
exercisable immediately after such adjustment.

        4.3.  Issuance of Additional Shares of Common Stock.  (a) If at any time
the Company shall issue or sell any Additional Shares of Common Stock in
exchange for consideration in an amount per Additional Share of Common Stock
less than the Current Market Price at the time the Additional Shares of Common
Stock are issued or sold, then (i) the number of shares of Common Stock for
which this Warrant is exercisable shall be adjusted to equal the product
obtained by multiplying the number of shares of Common Stock for which this
Warrant is exercisable immediately prior to such issue or sale by a fraction (A)
the numerator of which shall be the number of shares of Common Stock Outstanding
immediately after such issue or sale plus the number of shares of Common Stock
issuable pursuant to all Warrants outstanding immediately following such
issuance or sale, and (B) the denominator of which shall be the number of shares
of Common Stock Outstanding immediately prior to such issue or sale plus the
number of shares of Common Stock issuable pursuant to all Warrants outstanding
immediately prior to such issuance or sale plus the number of shares which the
aggregate offering price of the total number of such Additional Shares of Common
Stock would purchase at the then Current Market Price; and (ii) subject to
Section 4.10, the Current Warrant Price as to the number of shares for which
this Warrant is exercisable prior to such adjustment shall be adjusted by
multiplying such Current Warrant Price by a fraction (X) the numerator of which
shall be the number of shares for which this Warrant is exercisable immediately
prior to such issue or sale; and (Y) the denominator of which shall be the
number of shares of Common Stock purchasable immediately after such issue or
sale.

              (b) The provisions of paragraph (a) of Section 4.3 shall not apply
        to any issuance of Additional Shares of Common Stock for which an

                                       8
<PAGE>

        adjustment is provided under Section 4.1 or 4.2. No adjustment of the
        number of shares of Common Stock for which this Warrant shall be
        exercisable shall be made under paragraph (a) of Section 4.3 upon the
        issuance of any Additional Shares of Common Stock which are issued
        pursuant to the exercise of any warrants or other subscription or
        purchase rights or pursuant to the exercise of any conversion or
        exchange rights in any Convertible Securities, if any such adjustment
        shall previously have been made upon the issuance of such warrants or
        other rights or upon the issuance of such Convertible Securities (or
        upon the issuance of any warrant or other rights therefor) pursuant to
        Section 4.4 or Section 4.5.

        4.4.  Issuance of Warrants or Other Rights. If at any time the Company
shall take a record of the holders of its Common Stock for the purpose of
entitling them to receive a distribution of, or shall in any manner (whether
directly or by assumption in a merger in which the Company is the surviving
corporation) issue or sell, any warrants or other rights to subscribe for or
purchase any Additional Shares of Common Stock or any Convertible Securities,
whether or not the rights to exchange or convert thereunder are immediately
exercisable, and the price per share for which Common Stock is issuable upon the
exercise of such warrants or other rights or upon conversion or exchange of such
Convertible Securities shall be less than the Current Market Price in effect
immediately prior to the time of such issue or sale, then the number of shares
for which this Warrant is exercisable and the Current Warrant Price shall be
adjusted as provided in Section 4.3 on the basis that the maximum number of
Additional Shares of Common Stock issuable pursuant to all such warrants or
other rights or necessary to effect the conversion or exchange of all such
Convertible Securities shall be deemed to have been issued and outstanding and
the Company shall have received all of the consideration payable therefor, if
any, as of the date of the actual issuance of such warrants or other rights. No
further adjustments of the Current Warrant Price shall be made upon the actual
issue of such Common Stock or of such Convertible Securities upon exercise of
such warrants or other rights or upon the actual issue of such Common Stock upon
such conversion or exchange of such Convertible Securities.

        4.5.  Issuance of Convertible  Securities.  If at any time the Company
shall take a record of the holders of its Common Stock for the purpose of
entitling them to receive a distribution of, or shall in any manner (whether
directly or by assumption in a merger in which the Company is the surviving
corporation) issue or sell, any Convertible Securities, whether or not the
rights to exchange or convert thereunder are immediately exercisable, and the
price per share for which Common Stock is issuable upon such conversion or
exchange shall be less than the Current Market Price in effect immediately prior
to the time of such issue or sale, then the number of shares of Common Stock for
which this Warrant is exercisable and the Current Warrant Price shall be
adjusted as provided in Section 4.3 on the basis that the maximum number of
Additional Shares of Common Stock necessary to effect the conversion or exchange
of all such Convertible Securities shall be deemed to have been issued and
outstanding and the Company shall
                                       9

<PAGE>

have received all of the consideration payable therefor, if any, as of the date
of actual issuance of such Convertible Securities. No further adjustment of the
number of shares of Common Stock for which this Warrant is exercisable and the
Current Warrant Price shall be made under this Section 4.5 upon the issuance of
any Convertible Securities which are issued pursuant to the exercise of any
warrants or other subscription or purchase rights therefor, if any such
adjustment shall previously have been made upon the issuance of such warrants or
other rights pursuant to Section 4.4. No further adjustments of the number of
shares of Common Stock for which this Warrant is exercisable and the Current
Warrant Price shall be made upon the actual issue of such Common Stock upon
conversion or exchange of such Convertible Securities.

        4.6.  Superseding Adjustment.  If, at any time after any adjustment of
the number of shares of Common Stock for which this Warrant is exercisable and
the Current Warrant Price shall have been made pursuant to Section 4.4 or
Section 4.5 as the result of any issuance of warrants, other rights or
Convertible Securities,

              (a) such warrants or other rights, or the right of conversion or
        exchange in such other Convertible Securities, shall expire, and all or
        a portion of such warrants or other rights, or the right of conversion
        or exchange with respect to all or a portion of such other Convertible
        Securities, as the case may be, shall not have been exercised, or

              (b) the consideration per share for which shares of Common Stock
        are issuable pursuant to such warrants or other rights, or the terms of
        such other Convertible Securities, shall be increased by virtue of
        provisions therein contained for an automatic increase in such
        consideration per share upon the occurrence of a specified date or event
        or otherwise,

then for each outstanding Warrant such previous adjustment shall be recomputed
as if such event specified in paragraph (a) or (b) of this Section 4.6 had been
known at the time of such previous adjustment.

        4.7.  Other Provisions Applicable to Adjustments under this Section.
The following provisions shall be applicable to the making of adjustments of the
number of shares of Common Stock for which this Warrant is exercisable and the
Current Warrant Price provided for in this Section 4:

              (a) Computation of Consideration. To the extent that any
        Additional Shares of Common Stock or any Convertible Securities or any
        warrants or other rights to subscribe for or purchase any Additional
        Shares of Common Stock or any Convertible Securities shall be issued for
        cash consideration, the consideration received by the Company therefor
        shall be the amount of the cash received by the Company therefor, or, if
        such Additional Shares of Common

                                       10

<PAGE>

        Stock or Convertible Securities are offered by the Company for
        subscription, the subscription price, or, if such Additional Shares of
        Common Stock or Convertible Securities are sold to underwriters or
        dealers for public offering without a subscription offering, the initial
        public offering price (in any such case subtracting any amounts paid or
        receivable for accrued interest or accrued dividends and without taking
        into account any compensation, discounts or expenses paid or incurred by
        the Company for and in the underwriting of or otherwise in connection
        with, the issuance thereof). To the extent that such issuance shall be
        for a consideration other than cash, then, except as herein otherwise
        expressly provided, the amount of such consideration shall be deemed to
        be the fair value of such consideration at the time of such issuance as
        determined in good faith by the Board of Directors of the Company. In
        case any Additional Shares of Common Stock or any Convertible Securities
        or any warrants or other rights to subscribe for or purchase such
        Additional Shares of Common Stock or Convertible Securities shall be
        issued in connection with any merger in which the Company issues any
        securities, the amount of consideration therefor shall be deemed to be
        the fair value, as determined in good faith by the Board of Directors of
        the Company, of such portion of the assets and business of the
        nonsurviving corporation as such Board in good faith shall determine to
        be attributable to such Additional Shares of Common Stock, Convertible
        Securities, warrants or other rights, as the case may be. The
        consideration for any additional Shares of Common Stock issuable
        pursuant to any warrants or other rights to subscribe for or purchase
        the same shall be the consideration received by the Company for issuing
        such warrants or other rights plus the additional consideration payable
        to the Company upon exercise of such warrants or other rights. The
        consideration for any Additional Shares of Common Stock issuable
        pursuant to the terms of any Convertible Securities shall be the
        consideration received by the Company for issuing warrants or other
        rights to subscribe for or purchase such Convertible Securities, plus
        the consideration paid or payable to the Company in respect of the
        subscription for or purchase of such Convertible Securities, plus the
        additional consideration, if any, payable to the Company upon the
        exercise of the right of conversion or exchange in such Convertible
        Securities. In case of the issuance at any time of any Additional Shares
        of Common Stock or Convertible Securities in payment or satisfaction of
        any dividends upon any class of stock other than Common Stock, the
        Company shall be deemed to have received for such Additional Shares of
        Common Stock or Convertible Securities a consideration equal to the
        amount of such dividend so paid or satisfied. Whenever the Board of
        Directors of the Company shall be required to make a determination in
        good faith of the fair value of any consideration, such determination
        shall, if requested by Holder, be supported by an opinion of an
        investment banking firm of recognized national standing selected by the
        Company and acceptable to Holder (such acceptance not to be unreasonably
        withheld or delayed).

              (b) When Adjustments to Be Made. The adjustments required by this
        Section 4 shall be made whenever and as often as any specified event

                                       11
<PAGE>

        requiring an adjustment shall occur, except that any adjustment of the
        number of shares of Common Stock for which this Warrant is exercisable
        that would otherwise be required may be postponed (except in the case of
        a subdivision or combination of shares of the Common Stock, as provided
        for in Section 4.1) up to, but not beyond the date of exercise if such
        adjustment either by itself or with other adjustments not previously
        made adds or subtracts less than 1% of the shares of Common Stock for
        which this Warrant is exercisable immediately prior to the making of
        such adjustment. Any adjustment representing a change of less than such
        minimum amount (except as aforesaid) which is postponed shall be carried
        forward and made as soon as such adjustment, together with other
        adjustments required by this Section 4 and not previously made, would
        result in a minimum adjustment or on the date of exercise. For the
        purpose of any adjustment, any specified event shall be deemed to have
        occurred at the close of business on the date of its occurrence.

              (c) Fractional Interests. In computing adjustments under this
Section 4, fractional interests in Common Stock shall be taken into account to
the nearest 1/100th of a share.

              (d) When Adjustment Not Required. If the Company shall take a
record of the holders of its Common Stock for the purpose of entitling them to
receive a dividend or distribution or subscription or purchase rights and shall,
thereafter and before the distribution to stockholders thereof, legally abandon
its plan to pay or deliver such dividend, distribution, subscription or purchase
rights, then thereafter no adjustment shall be required by reason of the taking
of such record and any such adjustment previously made in respect thereof shall
be rescinded and annulled.

              (e) Escrow of Warrant Stock. If after any property becomes
distributable pursuant to this Section 4 by reason of the taking of any record
of the holders of Common Stock, but prior to the occurrence of the event for
which such record is taken, and Holder exercises this Warrant, any shares of
Common Stock issuable upon exercise by reason of such adjustment shall be deemed
the last shares of Common Stock for which this Warrant is exercised
(notwithstanding any other provision to the contrary herein) and such shares or
other property shall be held in escrow for Holder by the Company to be issued to
Holder upon and to the extent that the event actually takes place, upon payment
of the Current Warrant Price. Notwithstanding any other provision to the
contrary herein, if the event for which such record was taken fails to occur or
is rescinded, then such escrowed shares shall be cancelled by the Company and
escrowed property returned.

              (f) Challenge to Good Faith Determination. Whenever the Board of
Directors of the Company shall be required to make a determination in good faith
of the fair value of any item under this Section 4 in a situation in

                                       12

<PAGE>

which an opinion supporting such determination issued by an investment banking
firm acceptable to the Holder was not required to be delivered to the Holder,
such determination may be challenged in good faith by Holder, and any dispute
shall be resolved by an investment banking firm of recognized national standing
selected by the Company and acceptable to Holder.

                                       13

<PAGE>

     4.8.     Reorganization,   Reclassification,   Merger,  Consolidation  or
Disposition of Assets; Sale of Controlling Interest. (a) In case the Company
shall reorganize its capital, reclassify its capital stock, consolidate or merge
with or into another corporation (where the Company is not the surviving
corporation or where there is a change in or distribution with respect to the
Common Stock of the Company), or sell, transfer or otherwise dispose of all or
substantially all its property, assets or business to another corporation and,
pursuant to the terms of such reorganization, reclassification, merger,
consolidation or disposition of assets, shares of common stock of the successor
or acquiring corporation, or any cash, shares of stock or other securities or
property of any nature whatsoever (including warrants or other subscription or
purchase rights) in addition to or in lieu of common stock of the successor or
acquiring corporation ("Other Property"), are to be received by or distributed
to the holders of Common Stock of the Company, then Holder shall have the right
thereafter to receive, upon exercise of this Warrant, the number of shares of
common stock of the successor or acquiring corporation or of the Company, if it
is the surviving corporation, and Other Property receivable upon or as a result
of such reorganization, reclassification, merger, consolidation or disposition
of assets by a holder of the number of shares of Common Stock for which this
Warrant is exercisable immediately prior to such event; provided that, if any
portion of the Other Property shall consist of an interest in the Company, any
purchaser or successor thereof, or any affiliate thereof, the Company or such
successor or affiliate shall have the option to substitute for such portion of
Other Property, cash equal to the fair value thereof determined in good faith by
the Board of Directors of the Company and supported by an opinion of an
investment banking firm of recognized national standing acceptable to Holder
(which acceptance shall not be unreasonably withheld or delayed). In case of any
such reorganization, reclassification, merger, consolidation or disposition of
assets, the successor or acquiring corporation (if other than the Company) shall
expressly assume the due and punctual observance and performance of each and
every covenant and condition of this Warrant to be performed and observed by the
Company and all the obligations and liabilities hereunder, subject to such
modifications as may be deemed appropriate (as determined by resolution of the
Board of Directors of the Company) in order to provide for adjustments of shares
of the Common Stock for which this Warrant is exercisable which shall be as
nearly equivalent as practicable to the adjustments provided for in this Section
4. For purposes of this Section 4.8 "common stock of the successor or acquiring
corporation" shall include stock of such corporation of any class which is not
preferred as to dividends or assets on liquidation over any other class of stock
of such corporation and which is not subject to redemption and shall also
include any evidences of indebtedness, shares of stock or other securities which
are convertible into or exchangeable for any such stock, either immediately or
upon the arrival of a specified date or the happening of a specified event and
any warrants or other rights to subscribe for or purchase any such stock. The
foregoing provisions of this Section 4.8 shall similarly apply to successive
reorganizations reclassifications, mergers, consolidations or disposition of
assets.

              (b) Notwithstanding paragraph (a) of this Section 4.8 or any

                                       14
<PAGE>

        other provision of this Agreement, in the case that Lehman, any
        affiliate of Lehman or any Person or group in which Lehman or any
        affiliate has an interest acquires, directly or indirectly, a majority
        of the property, assets, business or capital stock of the Company (x)
        this Warrant shall be immediately cancelled and be of no further effect
        and (y) if any shares of Common Stock have been issued pursuant to this
        Warrant, such shares shall be immediately repurchased by the Company or
        its designee for a cash purchase price equal to the exercise price paid
        upon such issuance.

     4.9.     Other Action  Affecting Common Stock. In case at any time or from
time to time the Company shall take any action in respect of its Common Stock,
other than the payment of dividends permitted by Section 4.2(a) or any other
action described in this Section 4, then, unless such action will not have a
materially adverse effect upon the rights of Holder, the number of shares of
Common Stock or other stock for which this Warrant is exercisable and/or the
purchase price thereof shall b adjusted in such manner as may be equitable in
the circumstances.

     4.10.   No Adjustment Required.  Notwithstanding any provision in this
Warrant to the contrary, the Current Warrant Price shall in no event be less
than the par value of the Common Stock; provided, however, that the foregoing
minimum Current Warrant Price shall not be applicable for purposes of
determining adjustments to the number of shares issuable upon exercise of the
Warrant.

5.       NOTICES TO WARRANT HOLDERS

     5.1.     Notice of  Adjustments.  Whenever the number of shares of Common
Stock for which this Warrant is exercisable, or whenever the price at which a
share of such Common Stock may be purchased upon exercise of this Warrant, shall
be adjusted pursuant to Section 4, the Company shall forthwith prepare a
certificate to be executed by the chief financial or accounting officer of the
Company setting forth, in reasonable detail, the event requiring the adjustment
and the method by which such adjustment was calculated (including a description
of the basis on which the Board of Directors of the Company determined the fair
value of any evidences of indebtedness, shares of stock, other securities or
property or warrants or other subscription or purchase rights referred to in
Section 4.2 or 4.7(a)), specifying the number of shares of Common Stock for
which this Warrant is exercisable and (if such adjustment was made pursuant to
Section 4.8 or 4.9) describing the number and kind of any other shares of stock
or Other Property for which this Warrant is exercisable, and any change in the
purchase price or prices thereof, after giving effect to such adjustment or
change. The Company shall promptly cause a signed copy of such certificate to be
delivered to Holder in accordance with Section 17.2. The Company shall keep at
its office or agency designated pursuant to Section 12 copies of all such
certificates and cause the same to be available for inspection at said office
during normal business hours by Holder or any prospective purchaser of this
Warrant designated by Holder.

                                       15
<PAGE>

     5.2.     Notice of Corporate Action.  If at any time

              (a) the Company shall take a record of the holders of its Common
     Stock for the purpose of entitling them to receive a dividend (other than a
     cash dividend payable out of earnings or earned surplus legally available
     for the payment of dividends under the laws of the jurisdiction of
     incorporation of the Company) or other distribution, or any right to
     subscribe for or purchase any evidences of its indebtedness, any shares of
     stock of any class or any other securities or property, or to receive any
     other right, or

              (b) there shall be any capital reorganization of the Company, any
     reclassification or recapitalization of the capital stock of the Company or
     any consolidation or merger of the Company with, or any sale, transfer or
     other disposition of all or substantially all the property, assets or
     business of the Company to, another corporation, or

              (c) there shall be a voluntary or involuntary dissolution,
     liquidation or winding up of the Company;

then, in any one or more of such cases, the Company shall give to Holder (i) at
least 10 days' prior written notice of the date on which a record date shall be
selected for such dividend, distribution or right or for determining rights to
vote in respect of any such reorganization, reclassification, merger,
consolidation, sale, transfer, disposition, dissolution, liquidation or winding
up, and (ii) in the case of any such reorganization, reclassification, merger,
consolidation, sale, transfer, disposition dissolution, liquidation or winding
up, at least 10 days' prior written notice of the date when the same shall take
place. Such notice in accordance with the foregoing clause also shall specify
(i) the date on which any such record is to be taken for the purpose of such
dividend, distribution or right, the date on which the holders of Common Stock
shall be entitled to any such dividend, distribution or right, and the amount
and character thereof, and (ii) the date on which any such reorganization,
reclassification, merger, consolidation, sale, transfer, disposition,
dissolution, liquidation or winding up is to take place and the time, if any
such time is to be fixed, as of which the holders of Common Stock shall be
entitled to exchange their shares of Common Stock for securities or other
property deliverable upon such reorganization, reclassification, merger,
consolidation, sale, transfer, disposition, dissolution, liquidation or winding
up. Each such written notice shall be sufficiently given if addressed to Holder
at the last address of Holder appearing on the books of the Company and
delivered in accordance with Section 17.2.

     5.3.     Notice to Stockholders.  The Holder shall be entitled to the same
rights to receive notice of corporate action as any holder of Common Stock.

6.       NO IMPAIRMENT

              The Company shall not by any action including, without limitation,

                                       16
<PAGE>

amending its certificate of incorporation or through any reorganization,
transfer of assets, consolidation, merger, dissolution, issue or sale of
securities or any other voluntary action, avoid or seek to avoid the observance
or performance of any of the terms of this Warrant, but will at all times in
good faith assist in the carrying out of all such terms and in the taking of all
such actions as may be necessary or appropriate to protect the rights of Holder
against impairment. Without limiting the generality of the foregoing, the
Company will (a) not increase the par value of any shares of Common Stock
receivable upon the exercise of this Warrant above the amount payable therefor
upon such exercise immediately prior to such increase in par value, (b) take all
such action as may be necessary or appropriate in order that the Company may
validly and legally issue fully paid and nonassessable shares of Common Stock
upon the exercise of this Warrant, and (c) use its best efforts to obtain all
such authorizations, exemptions or consents from any public regulatory body
having jurisdiction thereof as may be necessary to enable the Company to perform
its obligations under this Warrant.

              Upon the request of Holder, the Company will at any time during
the period this Warrant is outstanding acknowledge in writing, in form
satisfactory to Holder, the continuing validity of this Warrant and the
obligations of the Company hereunder.

7.       RESERVATION AND AUTHORIZATION OF COMMON STOCK;
         REGISTRATION WITH OR APPROVAL OF ANY GOVERNMENTAL AUTHORITY

              From and after the Closing Date, the Company shall at all times
reserve and keep available for issue upon the exercise of Warrants such number
of its authorized but unissued shares of Common Stock as will be sufficient to
permit the exercise in full of all outstanding Warrants. All shares of Common
Stock which shall be so issuable, when issued upon exercise of any Warrant and
payment therefor in accordance with the terms of such Warrant, shall be duly and
validly issued and fully paid and nonassessable, and not subject to preemptive
rights.

              Before taking any action which would cause an adjustment reducing
the Current Warrant Price below the then par value, if any, of the shares of
Common Stock issuable upon exercise of the Warrants, the Company shall take any
corporate action which may be necessary in order that the Company may validly
and legally issue fully paid and non-assessable shares of such Common Stock at
such adjusted Current Warrant Price.

              Before taking any action which would result in an adjustment in
the number of shares of Common Stock for which this Warrant is exercisable or in
the Current Warrant Price, the Company shall obtain all such authorizations or
exemptions thereof, or consents thereto, as may be necessary from any public
regulatory body or bodies having jurisdiction thereof.

              If any shares of Common Stock required to be reserved for issuance
upon exercise of Warrants require registration or qualification with any
governmental authority

                                       17
<PAGE>

under any federal or state law (otherwise than as provided in Section 9) before
such shares may be so issued, the Company will in good faith and as
expeditiously as possible and at its expense endeavor to cause such shares to be
duly registered.

8.       TAKING OF RECORD; STOCK AND WARRANT TRANSFER BOOKS

              In the case of all dividends or other distributions by the Company
to the holders of its Common Stock with respect to which any provision of
Section 4 refers to the taking of a record of such holders, the Company will in
each such case take such a record and will take such record as of the close of
business on a Business Day. The Company will not at any time, except upon
dissolution, liquidation or winding up of the Company, close its stock transfer
books or Warrant transfer books so a to result in preventing or delaying the
exercise or transfer of any Warrant.

9.       RESTRICTIONS ON TRANSFERABILITY

              The Warrants and the Warrant Stock shall not be transferred,
hypothecated or assigned before satisfaction of the conditions specified in this
Section 9, which conditions are intended to ensure compliance with the
provisions of the Securities Act with respect to the Transfer of any Warrant or
any Warrant Stock. Holder, by acceptance of this Warrant, agrees to be bound by
the provisions of this Section 9. Prior to May 11, 2001, the Holder agrees not
to Transfer this Warrant, any shares o Warrant Stock or any interest in any of
the foregoing to any Person other than Lehman or a Person, the majority of the
common stock of which is owned by Lehman. In addition, Holder, by acceptance of
this Warrant, and any transferee or purchaser of Warrant Stock, by acceptance
thereof, shall be bound by the terms and conditions of Section 5 of the
Agreement dated May 11, 2000 by and among the Company, Conseco, Inc., CIHC,
Incorporated and Lehman Brothers Holdings Inc.

     9.1.     Restrictive Legend.  (a)  Except as otherwise provided in this
Section 9, each certificate for Warrant Stock initially issued upon the exercise
of this Warrant, and each certificate for Warrant Stock issued to any subsequent
transferee of any such certificate, shall be stamped or otherwise imprinted with
a legend in substantially the following form:

                  "The shares represented by this certificate have not been
              registered under the Securities Act of 1933, as amended, and are
              subject to the conditions specified in a certain Warrant dated May
              11, 2000, originally issued by Conseco Finance Corp. No transfer
              of the shares represented by this certificate shall be valid or
              effective until such conditions have been fulfilled. A copy of the
              form of said Warrant is on file with the Secretary of Conseco
              Finance Corp. The holder of this certificate, by acceptance of
              this certificate, agrees to be bound by the provisions of such
              Warrant. Such provisions include, among other things, the
              obligation to sell

                                       18
<PAGE>

              sell these shares to Conseco Finance Corp. or its designee under
              certain circumstances at the original exercise price of the
              Warrant.

                  In addition, the shares represented by this certificate are
              subject to certain drag-along and tag-along rights and obligations
              specified in a certain Agreement dated May 11, 2000 by and among
              Conseco Finance Corp., Conseco, Inc., CIHC, Incorporated and
              Lehman Brothers Holdings Inc. A copy of the form of said Agreement
              is on file with the Secretary of Conseco Finance Corp. The holder
              of this certificate, by acceptance of this certificate, agrees to
              be bound by the provisions of Section 5 of such Agreement. Such
              provisions include, among other things, the obligation to sell
              these shares under certain circumstances to persons acquiring all
              or a portion of the stock of Conseco Finance Corp."

              (b) Except as otherwise provided in this Section 9, each Warrant
        shall be stamped or otherwise imprinted with a legend in substantially
        the following form:

                  "This Warrant and the securities represented hereby have not
              been registered under the Securities Act of 1933, as amended, and
              may not be transferred in violation of such Act, the rules and
              regulations thereunder or the provisions of this Warrant."

     9.2.     Notice of Proposed Transfers; Requests for Registration. Prior to
any Transfer or attempted Transfer of any Warrant or any Restricted Common
Stock, the holder of such Warrant or Restricted Common Stock shall give 10 days'
prior written notice (a "Transfer Notice") to the Company of such holder's
intention to effect such Transfer, describing the manner and circumstances of
the proposed Transfer, and obtain from counsel to such holder who shall be
reasonably satisfactory to the Company, an opinion that the proposed Transfer of
such Warrant or Restricted Common Stock may be effected without registration
under the Securities Act. After receipt of the Transfer Notice and opinion, the
Company shall, within 5 days thereof, so notify the holder of such Warrant or
Restricted Common Stock and such holder shall thereupon be entitled to Transfer
such Warrant or Restricted Common Stock, in accordance with the terms of the
Transfer Notice. Each certificate, if any, evidencing such shares of Restricted
Common Stock issued upon such Transfer shall bear the restrictive legend set
forth in Section 9.1(a), and each Warrant issued upon such Transfer shall bear
the restrictive legend set forth in Section 9.1(b), unless in the opinion of
such counsel such legend is not required in order to ensure compliance with the
Securities Act. The holder of the Warrant or Restricted Common Stock, as the
case may be, giving the Transfer Notice shall not be entitled to transfer such
Warrant or Restricted Common Stock until receipt of notice from the Company
under this Section 9.2.

                                       19
<PAGE>

     9.3.     Incidental  Registration.  If the Company at any time proposes to
file on its behalf and/or on behalf of any of its security holders ("the
demanding security holders") a registration statement under the Securities Act
on any form (other than a registration statement on Form S-4 or S-8 or any
successor form for securities to be offered in a transaction of the type
referred to in Rule 145 under the Securities Act or to employees of the Company
pursuant to any employee benefit plan, respectively) for the general
registration of securities to be sold to the public for cash with respect to its
Common Stock or any other class of equity security (as defined in Section
3(a)(11) of the Exchange Act) of the Company, it will give written notice to all
holders of Warrants or Warrant Stock at least 15 days before the initial filing
with the Commission of such registration statement, which notice shall set forth
the intended method of disposition of the securities proposed to be registered
by the Company. The notice shall offer to include in such filing the aggregate
number of shares of Warrant Stock, and the number of shares of Common Stock for
which Warrants are exercisable, as such holders may request.

              Each holder of a Warrant or Warrant Stock desiring to have Warrant
Stock registered under this Section 9.3 shall advise the Company in writing
within 15 days after the date of receipt of such offer from the Company, setting
forth the amount of Warrant Stock for which registration is requested. The
Company shall thereupon include in such filing the number of shares of Warrant
Stock for which registration is so requested, subject to the next sentence, and
shall use all reasonable efforts to effect registration under the Securities Act
of such shares. If the managing underwriter of a proposed public offering shall
advise the Company in writing that, in its opinion, the distribution of the
Warrant Stock requested to be included in the registration concurrently with the
securities being registered by the Company or the demanding security holder or
holders would materially and adversely affect the distribution of such
securities by the Company or the demanding security holder or holders, the all
selling security holders shall reduce the amount of securities each intended to
distribute through such offering on a pro rata basis. Except as otherwise
provided in Section 9.5, all expenses of such registration shall be borne by the
Company.

     9.4.     Registration Procedures.  If the Company is required by the
provisions of this Section 9 to use all reasonable efforts to effect the
registration of any of its securities under the Securities Act, the Company
will, as expeditiously as possible:

              (a) prepare and file with the Commission a registration statement
        with respect to such securities and use its best efforts to cause such
        registration statement to become and remain effective for a period of
        time required for the disposition of such securities by the holders
        thereof, but not to exceed 180 days;

              (b) prepare and file with the Commission such amendments and
        supplements to such registration statement and the prospectus used in
        connection therewith as may be necessary to keep such registration
        statement effective and to comply with the provisions of the Securities
        Act with respect to the

                                       20
<PAGE>

        sale or other disposition of all securities covered by such registration
        statement until the earlier of such time as all of such securities have
        been disposed of in a public offering o the expiration of 180 days;

              (c) furnish to such selling security holders such number of copies
        of a summary prospectus or other prospectus, including a preliminary
        prospectus, in conformity with the requirements of the Securities Act,
        and such other documents, as such selling security holders may
        reasonably request;

              (d) use all reasonable efforts to register or qualify the
        securities covered by such registration statement under such other
        securities or blue sky laws of such jurisdictions within the United
        States and Puerto Rico as each holder of such securities shall request
        (provided, however, the Company shall not be obligated to qualify as a
        foreign corporation to do business under the laws of any jurisdiction in
        which it is not then qualified or to file any general consent to service
        or process), and do such other reasonable acts and things as may be
        required of it to enable such holder to consummate the disposition in
        such jurisdiction of the securities covered by such registration
        statement;

              (e) enter into customary agreements (including an underwriting
        agreement in customary form) and take such other actions as are
        reasonably required in order to expedite or facilitate the disposition
        of such registrable securities; and

              (f) otherwise use all reasonable efforts to comply with all
        applicable rules and regulations of the Commission, and make available
        to its security holders, as soon as reasonably practicable, but not
        later than 18 months after the effective date of the registration
        statement, an earnings statement covering the period of at least 12
        months beginning with the first full month after the effective date of
        such registration statement, which earnings statements shall satisfy the
        provisions of Section 11(a) of the Securities Act.

              It shall be a condition precedent to the obligation of the Company
to take any action pursuant to this Section 9 in respect of the securities which
are to be registered at the request of any holder of a Warrant or Warrant Stock
that such holder shall furnish to the Company such information regarding the
securities held by such holder and the intended method of disposition thereof as
the Company shall reasonably request and as shall be required in connection with
the action taken by the Company.

     9.5.     Expenses.  All expenses  incurred in  complying  with Section 9,
including, without limitation, all registration and filing fees (including all
expenses incident to filing with the NASD), printing expenses, fees and
disbursements of counsel for the Company, the reasonable fees and expenses of
one counsel for the selling security holders (selected by those holding a
majority of the shares being registered), expenses of any special audits
incident to or required by any such registration and expenses of

                                       21
<PAGE>

complying with the securities or blue sky laws of any jurisdictions pursuant to
Section 9.4(d), shall be paid by the Company, except that:

              (a) all such expenses in connection with any amendment or
        supplement to the registration statement or the prospectus filed more
        than 180 days after the effective date of such registration statement
        because any holder of Warrant Stock has not effected the disposition of
        the securities requested to be registered shall be paid by such holder;
        and

              (b) the Company shall not be liable for any fees, discounts or
        commissions to any underwriter or any fees or disbursements of counsel
        for any underwriter in respect of the securities sold by any holder of
        Warrant Stock.

     9.6.     Indemnification and Contribution.

              (a) In the event of any registration of any Warrant Stock under
     the Securities Act pursuant to this Section 9, the Company shall indemnify
     and hold harmless the holder of such Warrant Stock, such holder's directors
     and officers, and each other Person (including each underwriter) who
     participated in the offering of such Warrant Stock and each other Person,
     if any, who controls such holder or such participating Person within the
     meaning of the Securities Act, against any losses, claims, damages or
     liabilities, joint or several, to which such holder or any such director or
     officer or participating Person or controlling Person may become subject
     under the Securities Act or any other statute or at common law, insofar as
     such losses, claims, damages or liabilities (or actions in respect thereof)
     arise out of or are based upon (i) any alleged untrue statement of any
     material fact contained, on the effective date thereof, in any registration
     statement under which such securities were registered under the Securities
     Act, any preliminary prospectus or final prospectus contained therein, or
     any amendment or supplement thereto, or (ii) any alleged omission to state
     therein a material fact required to be stated therein or necessary to make
     the statements therein not misleading, and shall reimburse such holder or
     such director, officer or participating Person or controlling Person for
     any legal or any other expenses reasonably incurred by such holder or such
     director, officer or participating Person or controlling Person in
     connection with investigating or defending any such loss, claim, damage,
     liability or action; provided, however, that the Company shall not be
     liable in any such case to the extent that any such loss, claim, damage or
     liability arises out of or is based upon any alleged untrue statement or
     alleged omission made in such registration statement, preliminary
     prospectus, prospectus or amendment or supplement in reliance upon and in
     conformity with written information furnished to the Company by such holder
     specifically for use therein or so furnished for such purposes by any
     underwriter. Such indemnity shall remain in full force and effect
     regardless of any investigation made by or on behalf of such holder or such
     director, officer or participating Person or controlling Person, and shall
     survive the transfer of such securities by such holder.

                                       22
<PAGE>

              (b) Each holder of Warrant Stock, by acceptance thereof, agrees to
     indemnify and hold harmless the Company, its directors and officers and
     each other Person, if any, who controls the Company within the meaning of
     the Securities Act against any losses, claims, damages or liabilities,
     joint or several, to which the Company or any such director or officer or
     any such Person may become subject under the Securities Act or any other
     statute or at common law, insofar as such losses, claims, damages or
     liabilities (or actions in respect thereof) arise out of or are based upon
     information in writing provided to the Company by such holder of Warrant
     Stock contained, on the effective date thereof, in any registration
     statement under which securities were registered under the Securities Act
     at the request of such holder, any preliminary prospectus or final
     prospectus contained therein, or any amendment or supplement thereto;
     provided, however, that the indemnification obligations of such holder
     shall be limited to the gross proceeds from the offering of Warrant Stock
     received by such holder.

              (c) If the indemnification provided for in this Section 9.6 from
     the indemnifying party is unavailable to an indemnified party hereunder in
     respect of any losses, claims, damages, liabilities or expenses referred to
     therein, then the indemnifying party, in lieu of indemnifying such
     indemnified party, shall contribute to the amount paid or payable by such
     indemnified party as a result of such losses, claims, damages, liabilities
     or expenses in such proportion as is appropriate to reflect the relative
     fault of the indemnifying party and indemnified parties in connection with
     the actions which resulted in such losses, claims, damages, liabilities or
     expenses, as well as any other relevant equitable considerations. The
     relative fault of such indemnifying party and indemnified parties shall be
     determined by reference to, among other things, whether any action in
     question, including any untrue or alleged untrue statement of a material
     fact or omission or allege omission to state a material fact, has been made
     by, or relates to information supplied by, such indemnifying party or
     indemnified parties, and the parties' relative intent, knowledge, access to
     information and opportunity to correct or prevent such action. The amount
     paid or payable by a party as a result of the losses, claims, damages,
     liabilities and expenses referred to above shall be deemed to include any
     legal or other fees or expenses reasonably incurred by such party in
     connection with any investigation or proceeding provided, however, that the
     contribution obligation of any holder shall be limited to the gross
     proceeds from the offering of the Warrant Stock received by any such
     holder.

              The parties hereto agree that it would not be just and equitable
     if contribution pursuant to this Section 9.6(c) were determined by pro rata
     allocation or by any other method of allocation which does not take account
     of the equitable considerations referred to in the immediately preceding
     paragraph. No Person guilty of fraudulent misrepresentation (within the
     meaning of Section 11(f) of the
                                       23
<PAGE>

     Securities Act) shall be entitled to contribution from any Person who was
     not guilty of such fraudulent misrepresentation.

     9.7.     Termination  of  Restrictions.   Notwithstanding  the  foregoing
provisions of Section 9, the securities law restrictions imposed by this Section
9 upon the transferability of the Warrants and the Restricted Common Stock and
the legend requirements of Section 9.1 insofar as they relate to securities law
compliance shall terminate as to any particular Warrant or Restricted Common
Stock (i) when and so long as such security shall have been effectively
registered under the Securities Act and disposed of pursuant thereto or (ii)
when the Company shall have received an opinion of counsel reasonably
satisfactory to it that such shares may be transferred without registration
thereof under the Securities Act. Whenever any restriction imposed by Section 9
shall terminate as to this Warrant, as hereinabove provided, the Holder hereof
shall be entitled to receive from the Company, at the expense of the Company, a
new Warrant bearing the following legend in place of the restrictive legend set
forth hereon:

                  "THE RESTRICTIONS ON TRANSFERABILITY WITH RESPECT TO
              SECURITIES LAW COMPLIANCE OF THE WITHIN WARRANT CONTAINED IN
              SECTION 9.2 HEREOF TERMINATED ON ______________, 2000, AND ARE OF
              NO FURTHER FORCE AND EFFECT."

All Warrants issued upon registration of transfer, division or combination of,
or in substitution for, any Warrant or Warrants entitled to bear such legend
shall have a similar legend endorsed thereon. Whenever the restrictions imposed
by this Section 9 shall terminate as to any share of Restricted Common Stock, as
hereinabove provided, the holder thereof shall be entitled to receive from the
Company, at the Company's expense, a new certificate representing such Common
Stock not bearing the restrictive legend set forth in Section 9.1(a).

     9.8.     Listing on Securities Exchange.  If the Company shall list any
shares of Common Stock on any securities exchange, it will, at its expense, list
thereon, maintain and, when necessary, increase such listing of, all shares of
Common Stock issued or, to the extent permissible under the applicable
securities exchange rules, issuable upon the exercise of the Warrants so long as
any shares of Common Stock shall be so listed during any such Exercise Period.

     9.9.     Certain Limitations on Registration  Rights.  Notwithstanding the
other provisions of Section 9, the Company shall not be obligated to register
Warrant Stock of any holder if, in the opinion of counsel to the Company
reasonably satisfactory to such holder and its counsel (or, if such holder has
engaged an investment banking firm, to such investment banking firm and its
counsel), the sale or other disposition of such holder's Warrant Stock, in the
manner and under the conditions proposed by such holder (or by such investment
banking firm), may be effected without registering such Warrant Stock under the
Securities Act.

                                       24
<PAGE>

10.      SUPPLYING INFORMATION

              The Company shall cooperate with Holder and each holder of
Restricted Common Stock in supplying such information as may be reasonably
necessary for such holder to complete and file any information reporting forms
presently or hereafter required by the Commission as a condition to the
availability of an exemption from the registration requirements of the
Securities Act for the sale of any Warrant or Restricted Common Stock.

11.     LOSS OR MUTILATION

              Upon receipt by the Company from Holder of evidence reasonably
satisfactory to it of the ownership of and the loss, theft, destruction or
mutilation of this Warrant and indemnity reasonably satisfactory to it (it being
understood that the written agreement of the original Holder shall be sufficient
indemnity) and in case of mutilation upon surrender and cancellation hereof, the
Company will execute and deliver in lieu hereof a new Warrant of like tenor to
Holder; provided, however, that in the case of mutilation, no indemnity shall be
required if this Warrant in identifiable form is surrendered to the Company for
cancellation.

12.      OFFICE OF THE COMPANY

              As long as any of the Warrants remain outstanding, the Company
shall maintain an office or agency (which may be the principal executive offices
of the Company) where the Warrants may be presented for exercise, registration
of transfer, division or combination as provided in this Warrant.

13.      FINANCIAL AND BUSINESS INFORMATION

     13.1.    Quarterly Information. Subject to Section 13.5, the Company will
deliver to Holder or any holder of Warrant Stock, as soon as available and in
any event within 60 days after the end of each of the first three quarters of
each fiscal year of the Company, one copy of an unaudited consolidated balance
sheet of the Company and its subsidiaries as at the end of such quarter, and the
related unaudited consolidated statements of income, retained earnings and cash
flow of the Company and its subsidiaries for such quarter and, in the case of
the second and third quarters, for the portion of the fiscal year ending with
such quarter, setting forth in each case in comparative form the figures for the
corresponding periods in the previous fiscal year. Such financial statements
shall be prepared by the Company in accordance with GAAP and accompanied by the
certification of the Company's chief executive officer or chief financial
officer that such financial statements present fairly the consolidated financial
position, results of operations and cash flow of the Company and its
subsidiaries as at the end of such quarter and for such year-to-date period, as
the case may be.

     13.2.    Annual  Information.  Subject to Section 13.5, the Company will

                                       25
<PAGE>

deliver to Holder or any holder of Warrant Stock as soon as available and in any
event within 120 days after the end of each fiscal year of the Company, one copy
of an audited consolidated balance sheet of the Company and its subsidiaries as
at the end of such year, and audited consolidated statements of income, retained
earnings and cash flow of the Company and its subsidiaries for such year;
setting forth in each case in comparative form the figures for the corresponding
periods in the previous fiscal year; all prepared in accordance with GAAP, and
which audited financial statements shall be accompanied by (i) an opinion
thereon of the independent certified public accountants regularly retained by
the Company, or any other firm of independent certified public accountants of
recognized national standing selected by the Company and (ii) a report of such
independent certified public accountants confirming any adjustment made pursuant
to Section 4 during such year.

     13.3.    Filings.  Subject to Section 13.5,  the Company will file on or
before the required date all regular or periodic reports (pursuant to the
Exchange Act) with the Commission and will deliver to Holder and any holder of
Warrant Stock promptly upon their becoming available one copy of each report,
notice or proxy statement sent by the Company to its stockholders generally, and
of each regular or periodic report (pursuant to the Exchange Act) and any
registration statement, prospectus or written communication (other than
transmittal letters) (pursuant to the Securities Act), filed by the Company with
(i) the Commission or (ii) any securities exchange on which shares of Common
Stock are listed.

     13.4.    Access.  At any reasonable time, at reasonable intervals and upon
reasonable advance notice, the Company shall permit any holder of Warrants or
Warrant Stock and any authorized agent or representative thereof to (a) visit
the properties of the Company and any of its subsidiaries and (b) discuss the
affairs, finances and accounts of the Company and any of its subsidiaries with
any of their respective officers or directors.

     13.5.    EDGAR Filings.  Notwithstanding anything in Sections 13.1, 13.2
or 13.3 to the contrary, the Company shall not be obligated to provide to Holder
any documents or portions thereof required to be sent to Holder under such
sections to the extent that such documents or portions thereof are filed
electronically by the Company with the Securities and Exchange Commission and
made available for public access through the SEC's EDGAR system.

14.      REPURCHASE BY THE COMPANY OF WARRANT AND WARRANT STOCK

     14.1.    Obligation to Repurchase Warrant and Warrant Stock.

              (a) From time to time on or after the third anniversary of the
     Closing Date and until the Expiration Date, upon written notice from
     Holders and holders of Warrant Stock owning at least a majority of the
     total outstanding Warrants and shares of Warrant Stock, taken together as a
     whole, the Company shall repurchase, on the date and in the manner set
     forth in Section 14.2 below,

                                       26
<PAGE>

     from all Holders and all holders of Warrant Stock all (but not less than
     all) of the Warrants and all (but not less than all) of any shares of
     Warrant Stock outstanding. The amount payable by the Company for such
     repurchase shall be determined (i) with respect to any Warrant, by
     multiplying (A) the number of shares of Common Stock subject to such
     Warrant by (B) the difference between the Current Market Price per share of
     Common Stock as of the date of such notice and the Current Warrant Price
     per share of Common Stock as of the date of such notice and (ii) with
     respect to any shares of Warrant Stock, by multiplying (A) the number of
     shares of Warrant Stock by (B) the Current Market Price per share of Common
     Stock as of the date of such notice. Nothing herein shall preclude the
     exercise by Holder of any portion of this Warrant exercisable at any time
     prior to such repurchase.

              (b) Notwithstanding the provisions of Section 14.1(a), if, at any
     time during the period between the date on which the Holders and holders of
     Warrant Stock (if any) shall have exercised their rights under Section 14.1
     to cause the Company to repurchase all of the Warrants and any Warrant
     Stock outstanding and, on or prior to the date of such repurchase, the
     Company shall consolidate or merge with, or sell all or substantially all
     of its property and assets to, any Person, then Holders shall (whether or
     not Holder shall have previously surrendered this Warrant for repurchase by
     the Company pursuant to this Section 14) be entitled to receive, on the
     date of such repurchase, the higher of (i) the amount payable to the
     Holders as determined pursuant to Section 14.1(a) and (ii) an amount equal
     to the sum of (A) the amount of cash the Holders would have received upon
     such consolidation, merger or sale had all Warrants been exercised
     immediately prior thereto, plus (B) the amount equal to the cash value,
     determined in the good faith judgment of the Board of Directors of the
     Company, of any other consideration the Holders would have received upon
     such consolidation, merger or sale had the Warrants been fully exercised
     immediately prior thereto less the purchase price payable at such time for
     the purchase of the shares of Common Stock then subject to the Warrants.

     14.2.    Determination and Payment of Repurchase Price.

              (a) The purchase price for any repurchase pursuant to this
     Section 14 (the "Repurchase Price") shall be determined within 90 days of
     the date of the repurchase notice received by the Company pursuant to
     Section 14.1 or as of the date the repurchase notice was delivered to the
     Holder pursuant to Section 14.3 (as the case may be), and shall be payable
     in cash within 20 days following the date of such determination of the
     Repurchase Price. On the date of any repurchase of this Warrant and any
     Warrant Stock pursuant to this Section 14, the Holders and holders of
     Warrant Stock shall assign to the Company the Warrants and any shares of
     Warrant Stock, as the case may be, without any representation or warranty
     (other than as to title), by the surrender of the Warrants

                                       27
<PAGE>

     and any Warrant Stock at the principal office of the Company referred to in
     Section 2.1 against payment therefor of the Repurchase Price by, at the
     option of Holder, (i) wire transfer to an account in a bank located in the
     United States designated by each Holder for such purpose and/or (ii) a
     certified or official bank check drawn on a member of the New York Clearing
     House payable to the order of each Holder.

              (b) Any repurchase by the Company of all or any portion of the
     Warrants pursuant to Section 14.1 or 14.3 which is delayed by the failure
     of the Company to determine the Repurchase Price within the time periods
     required in Section 14.2(a) shall be consummated within 10 days after the
     determination of the Repurchase Price.

     14.3.    Option to Repurchase  Warrant and Warrant Stock.  If and to the
extent that the Holders and holders of Warrant Stock do not exercise their right
to cause the Company to repurchase this Warrant and any Warrant Stock within 30
days after the third anniversary of the Closing Date, upon written notice from
the Company, the Company may thereafter repurchase all (but not less than all)
of this Warrant and all (but not less than all) shares of Warrant Stock. The
amount payable by the Company shall equal the Repurchase Price, as determined in
Sections 14.1 and 14.2 above. The provisions of Section 14.2 shall apply to any
repurchase under this Section 14.3.

15.      APPRAISAL

              The determination of the Appraised Value per share of Common Stock
shall be made by an investment banking firm of nationally recognized standing
selected by the Company and acceptable to Holder (which acceptance shall not be
unreasonably withheld or delayed). If the investment banking firm selected by
the Company is not acceptable to Holder and the Company and Holder cannot agree
on a mutually acceptable investment banking firm, then Holder and the Company
shall each choose one such investment banking firm and the respective chosen
firms shall agree on another investment banking firm which shall make the
determination. The Company shall retain, at its sole cost, such investment
banking firm as may be necessary for the determination of Appraised Value
required by the terms of this Warrant.

16.      LIMITATION OF LIABILITY

              No provision hereof, in the absence of affirmative action by
Holder to purchase shares of Common Stock, and no enumeration herein of the
rights or privileges of Holder hereof, shall give rise to any liability of
Holder for the purchase price of any Common Stock or as a stockholder of the
Company, whether such liability is asserted by the Company or by creditors of
the Company.

                                       28
<PAGE>

17.      MISCELLANEOUS

     17.1.    Nonwaiver and Expenses.  No course of dealing or any delay or
failure to exercise any right hereunder on the part of Holder shall operate as a
waiver of such right or otherwise prejudice Holder's rights, powers or remedies.
If the Company fails to make, when due, any payments provided for hereunder, or
fails to comply with any other provision of this Warrant, the Company shall pay
to Holder such amounts as shall be sufficient to cover any costs and expenses
including, but not limited to, reasonable attorneys' fees, including those of
appellate proceedings, incurred by Holder in collecting any amounts due pursuant
hereto or in otherwise enforcing any of its rights, powers or remedies
hereunder.

     17.2.    Notice Generally.  Any notice, demand, request, consent, approval,
declaration, delivery or other communication hereunder to be made pursuant to
the provisions of this Warrant shall be sufficiently given or made if in writing
and either delivered in person with receipt acknowledged or sent by registered
or certified mail, return receipt requested, postage prepaid, addressed as
follows:

              (a) If to Holder or any holder of Warrant Stock, at its last known
        address appearing on the books of the Company maintained for such
        purpose.

              (b) If to the Company at

              Conseco Finance Corp.
              1100 Landmark Towers
              345 Saint Peters Street
              Saint Paul, Minnesota 55102-1639
              Attention: Corporate Secretary

              With a copy to:

              Conseco, Inc.
              11825 N. Pennsylvania Street
              Carmel, Indiana 46032
              Attention: Corporate Secretary

or at such other address as may be substituted by notice given as herein
provided. The giving of any notice required hereunder may be waived in writing
by the party entitled to receive such notice. Every notice, demand, request,
consent, approval, declaration, delivery or other communication hereunder shall
be deemed to have been duly given or served on the date on which personally
delivered, with receipt acknowledged, or three Business Days after the same
shall have been deposited in the United States mail as provided in this Section
17.2. Failure or delay in delivering copies of any notice, demand, request,
approval, declaration, delivery or other communication to the person

                                       29
<PAGE>

designated above to receive a copy shall in no way adversely affect the
effectiveness of such notice, demand, request, approval, declaration, delivery
or other communication.

     17.3.    Indemnification.  The  Company  agrees  to  indemnify  and hold
harmless Holder from and against any liabilities, obligations, losses, damages,
penalties, actions, judgments, suits, claims, costs, attorneys' fees, expenses
and disbursements of any kind which may be imposed upon, incurred by or asserted
against Holder in any manner relating to or arising out of (i) Holder's exercise
of this Warrant and/or ownership of any shares of Warrant Stock issued in
consequence thereof, or (ii) any litigation to which Holder is made a party in
its capacity as a stockholder or warrantholder of the Company; provided,
however, that the Company will not be liable hereunder to the extent that any
liabilities, obligations, losses, damages, penalties, actions, judgments, suits,
claims, costs, attorneys' fees, expenses or disbursements are found in a final
non-appealable judgment by a court to have resulted from Holder's gross
negligence, bad faith or willful misconduct in its capacity as a stockholder or
warrantholder of the Company.

     17.4.    Remedies. Holder, each holder of Warrant Stock and the Company, in
addition to being entitled to exercise all rights granted by law, including
recovery of damages, will be entitled to specific performance of its rights
under this Warrant. Holder, by acceptance of this Warrant, each holder of
Warrant Stock, by acceptance of such stock, and the Company each agrees that
monetary damages may not be adequate compensation for any loss incurred by
reason of a breach by it of this Warrant and hereby agrees to waive the defense
in any action for specific performance that a remedy at law would be adequate.

     17.5.    Successors and Assigns.  Subject to compliance with the provisions
of Sections 3.1 and 9, this Warrant and the rights evidenced hereby shall inure
to the benefit of and be binding upon the successors of the Company and the
successors and assigns of Holder. The provisions of this Warrant are intended to
be for the benefit of all Holders from time to time of this Warrant, and shall
be enforceable by any such Holder.

     17.6.    Amendment.  This Warrant may be modified or amended or the
provisions of this Warrant waived with the written consent of the Company and
Holder.

     17.7.    Severability.  Wherever possible, each provision of this Warrant
shall be interpreted in such manner as to be effective and valid under
applicable law, but if any provision of this Warrant shall be prohibited by or
invalid under applicable law, such provision shall be ineffective to the extent
of such prohibition or invalidity, without invalidating the remainder of such
provision or the remaining provisions of this Warrant.

     17.8.    Headings.  The headings used in this Warrant are for the
convenience of reference only and shall not, for any purpose, be deemed a part
of this Warrant.

                                       30
<PAGE>

     17.9.    Governing Law.  This Warrant shall be governed by, and be
construed and interpreted in accordance with, the law of the State of New York.

     17.10.   Effective Date.  This Warrant and any Warrant issued in exchange
or substitution for or upon a transfer of this Warrant shall be dated the
Closing Date and all adjustments provided for herein to the exercise price and
number of shares of Common Stock for which this or such other Warrant is
exercisable shall be made on the basis of transactions occurring from and after
the Closing Date.

              IN WITNESS WHEREOF, the Company has caused this Warrant to be duly
executed and its corporate seal to be impressed hereon and attested by its
Secretary or an Assistant Secretary.

Dated: May 11, 2000

                                       CONSECO FINANCE CORP.

                                       By: /s/ Thomas J. Kilian
                                           ---------------------------------
                                           Name:   Thomas J. Kilian
                                           Title:  President

Attest:

By: /s/ John J. Sabl
    ---------------------------
    Name:   John J. Sabl
    Title:  Assistant Secretary

                                       31
<PAGE>

              The undersigned holder of this Warrant agrees to be bound by the
terms of this Warrant so long as the undersigned owns all or any portion of this
Warrant or any shares of Warrant Stock.

                                       LEHMAN BROTHERS HOLDINGS INC.

                                       By:  /s/ Karen Manson
                                            ----------------------------
                                            Name:   Karen Manson
                                            Title:  Vice President

                                       32

<PAGE>

                                    EXHIBIT A

                                SUBSCRIPTION FORM

                 [To be executed only upon exercise of Warrant]

              The undersigned registered owner of this Warrant irrevocably
exercises this Warrant for the purchase of ______ shares of Common Stock of
Conseco Finance Corp., and herewith makes payment therefor, all at the price and
on the terms and conditions specified in this Warrant and requests that
certificates for the shares of Common Stock hereby purchased (and any securities
or other property issuable upon such exercise) be issued in the name of and
delivered to ____________________ whose address is ____________________________
and, if such shares of Common Stock shall not include all of the shares of
Common Stock issuable as provided in this Warrant, that a new Warrant of like
tenor and date for the balance of the shares of Common Stock issuable hereunder
be delivered to the undersigned.

                                       ____________________________________
                                       (Name of Registered Owner)

                                       ____________________________________
                                       (Signature of Registered Owner)

                                       ____________________________________
                                       (Street Address)

                                       ____________________________________

                                       (City)       (State)      (Zip Code)

NOTICE:  The signature on this subscription must correspond with the name as
         written upon the face of the Warrant in every particular, without
         alteration or enlargement or any change whatsoever.

                                      A-1

<PAGE>

                                    EXHIBIT B

                                 ASSIGNMENT FORM

              FOR VALUE RECEIVED the undersigned registered owner of this
Warrant hereby sells, assigns and transfers unto the Assignee named below all of
the rights of the undersigned under this Warrant, with respect to the number of
shares of Common Stock set forth below:

Name and Address of Assignee                    No. of Shares of
                                                Common Stock

and does hereby irrevocably constitute and appoint _______ ________________
attorney-in-fact to register such transfer on the books of
______________________, maintained for the purpose, with full power of
substitution in the premises.

Dated: _____________________           Print Name:
                                       Signature:
                                       Witness:

NOTICE:  The signature on this assignment must correspond with the name as
         written upon the face of the Warrant in every particular, without
         alteration or enlargement or any change whatsoever.

                                      B-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00013-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00013-of-00352.parquet"}]]